| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | aspartic-type endopeptidase activity | 1.24e-04 | 37 | 139 | 4 | GO:0004190 | |
| GeneOntologyMolecularFunction | aspartic-type peptidase activity | 1.38e-04 | 38 | 139 | 4 | GO:0070001 | |
| GeneOntologyBiologicalProcess | DNA damage response | FOXO1 ATRX POLA1 BAZ1B RAD9B ERVK-7 APLF ASH2L EMSY DDX1 HNRNPK CDC7 NEDD4 PARP1 BRCA2 KHDC3L POLQ NFAT5 USP1 SHLD3 UVRAG | 1.43e-06 | 959 | 137 | 21 | GO:0006974 |
| GeneOntologyBiologicalProcess | Sertoli cell development | 1.79e-05 | 24 | 137 | 4 | GO:0060009 | |
| GeneOntologyBiologicalProcess | replication fork processing | 2.43e-05 | 52 | 137 | 5 | GO:0031297 | |
| GeneOntologyBiologicalProcess | DNA-templated DNA replication | 2.55e-05 | 178 | 137 | 8 | GO:0006261 | |
| GeneOntologyBiologicalProcess | DNA repair | ATRX POLA1 RAD9B ERVK-7 APLF EMSY DDX1 CDC7 PARP1 BRCA2 KHDC3L POLQ USP1 SHLD3 UVRAG | 2.74e-05 | 648 | 137 | 15 | GO:0006281 |
| GeneOntologyBiologicalProcess | DNA-templated DNA replication maintenance of fidelity | 4.89e-05 | 60 | 137 | 5 | GO:0045005 | |
| GeneOntologyBiologicalProcess | double-strand break repair | 6.28e-05 | 324 | 137 | 10 | GO:0006302 | |
| GeneOntologyBiologicalProcess | Sertoli cell differentiation | 6.56e-05 | 33 | 137 | 4 | GO:0060008 | |
| GeneOntologyBiologicalProcess | response to abiotic stimulus | FOXO1 USP53 CACNA1F NOG ACADL POLA1 SYNE1 CKAP5 RAD9B ZZEF1 FABP1 HP1BP3 NEDD4 PARP1 ADSS2 BRCA2 SCN7A TRPM8 NFAT5 USP1 CNN2 PICK1 | 9.06e-05 | 1361 | 137 | 22 | GO:0009628 |
| GeneOntologyBiologicalProcess | regulation of vesicle-mediated transport | ANK3 SYNE1 CKAP5 UNC13D HNRNPK NEDD4 SEPTIN2 RAB3GAP1 ALMS1 SYT1 C4A C4B CNN2 PICK1 | 1.45e-04 | 667 | 137 | 14 | GO:0060627 |
| GeneOntologyBiologicalProcess | double-strand break repair via nonhomologous end joining | 1.62e-04 | 77 | 137 | 5 | GO:0006303 | |
| GeneOntologyCellularComponent | cytoplasmic stress granule | 4.23e-05 | 96 | 138 | 6 | GO:0010494 | |
| GeneOntologyCellularComponent | cytoplasmic ribonucleoprotein granule | 7.65e-05 | 269 | 138 | 9 | GO:0036464 | |
| GeneOntologyCellularComponent | ribonucleoprotein granule | 1.25e-04 | 287 | 138 | 9 | GO:0035770 | |
| GeneOntologyCellularComponent | dendrite | CHL1 FLNA ANK3 MAP6 SYNE1 CKAP5 HNRNPK NEDD4 BMPR1B GLRB UNC5C C4A C4B HSPA5 PICK1 | 5.55e-04 | 858 | 138 | 15 | GO:0030425 |
| GeneOntologyCellularComponent | dendritic tree | CHL1 FLNA ANK3 MAP6 SYNE1 CKAP5 HNRNPK NEDD4 BMPR1B GLRB UNC5C C4A C4B HSPA5 PICK1 | 5.69e-04 | 860 | 138 | 15 | GO:0097447 |
| HumanPheno | Joint stiffness | 1.10e-05 | 202 | 47 | 10 | HP:0001387 | |
| HumanPheno | Short long bone | FLNA COL9A1 NOG DYNC2H1 ZNF407 CUL7 SUCLG1 BMPR1B BRCA2 UBAP2L HEPHL1 | 3.14e-05 | 278 | 47 | 11 | HP:0003026 |
| HumanPheno | Aplasia/hypoplasia involving bones of the lower limbs | FLNA AARS1 COL9A1 NOG AIMP1 DYNC2H1 SPART ZNF407 SUCLG1 BMPR1B ALMS1 UBAP2L HEPHL1 SPEN | 5.75e-05 | 474 | 47 | 14 | HP:0006493 |
| HumanPheno | Distal symphalangism of hands | 5.95e-05 | 9 | 47 | 3 | HP:0001204 | |
| HumanPheno | Toe clinodactyly | 8.20e-05 | 26 | 47 | 4 | HP:0001863 | |
| HumanPheno | Distal symphalangism | 8.44e-05 | 10 | 47 | 3 | HP:0100263 | |
| HumanPheno | Abnormal lower limb bone morphology | FLNA AARS1 COL9A1 NOG ATRX AIMP1 DYNC2H1 SPART ZNF407 CUL7 SUCLG1 HNRNPK BMPR1B ALMS1 BRCA2 UBAP2L SYT1 HEPHL1 SPEN | 1.15e-04 | 866 | 47 | 19 | HP:0040069 |
| HumanPheno | Limb undergrowth | FLNA AARS1 COL9A1 NOG AIMP1 DYNC2H1 ZNF407 CUL7 SUCLG1 BMPR1B BRCA2 UBAP2L HEPHL1 | 1.25e-04 | 444 | 47 | 13 | HP:0009826 |
| HumanPheno | Hypoplasia of the ulna | 1.33e-04 | 55 | 47 | 5 | HP:0003022 | |
| Domain | - | 1.48e-04 | 39 | 129 | 4 | 3.30.1370.10 | |
| Domain | CH | 1.50e-04 | 73 | 129 | 5 | PS50021 | |
| Domain | CH-domain | 1.70e-04 | 75 | 129 | 5 | IPR001715 | |
| Domain | KH_TYPE_1 | 1.98e-04 | 42 | 129 | 4 | PS50084 | |
| Domain | KH_dom_type_1 | 2.38e-04 | 44 | 129 | 4 | IPR004088 | |
| Domain | Calponin/LIMCH1 | 2.81e-04 | 4 | 129 | 2 | IPR001997 | |
| Domain | Anaphylatoxin_comp_syst | 4.67e-04 | 5 | 129 | 2 | IPR018081 | |
| Domain | Anaphylatoxn_comp_syst_dom | 4.67e-04 | 5 | 129 | 2 | IPR001840 | |
| Domain | ANATO | 9.72e-04 | 7 | 129 | 2 | SM00104 | |
| Domain | APC_su10/DOC_dom | 9.72e-04 | 7 | 129 | 2 | IPR004939 | |
| Domain | DOC | 9.72e-04 | 7 | 129 | 2 | PS51284 | |
| Domain | ANAPHYLATOXIN_2 | 9.72e-04 | 7 | 129 | 2 | PS01178 | |
| Domain | ANAPHYLATOXIN_1 | 9.72e-04 | 7 | 129 | 2 | PS01177 | |
| Domain | ANAPC10 | 9.72e-04 | 7 | 129 | 2 | PF03256 | |
| Domain | ANATO | 9.72e-04 | 7 | 129 | 2 | PF01821 | |
| Domain | APC10 | 9.72e-04 | 7 | 129 | 2 | SM01337 | |
| Domain | Anaphylatoxin/fibulin | 9.72e-04 | 7 | 129 | 2 | IPR000020 | |
| Domain | CH | 1.06e-03 | 65 | 129 | 4 | SM00033 | |
| Domain | DAD_dom | 1.29e-03 | 8 | 129 | 2 | IPR014767 | |
| Domain | MacrogloblnA2_thiol-ester-bond | 1.29e-03 | 8 | 129 | 2 | IPR019565 | |
| Domain | DAD | 1.29e-03 | 8 | 129 | 2 | PS51231 | |
| Domain | Thiol-ester_cl | 1.29e-03 | 8 | 129 | 2 | PF10569 | |
| Domain | MacrogloblnA2_CS | 1.29e-03 | 8 | 129 | 2 | IPR019742 | |
| Domain | CH | 1.40e-03 | 70 | 129 | 4 | PF00307 | |
| Domain | - | 1.48e-03 | 71 | 129 | 4 | 1.10.418.10 | |
| Domain | Drf_GBD | 1.65e-03 | 9 | 129 | 2 | PF06371 | |
| Domain | Drf_FH3 | 1.65e-03 | 9 | 129 | 2 | PF06367 | |
| Domain | ZU5 | 1.65e-03 | 9 | 129 | 2 | SM00218 | |
| Domain | FH3_dom | 1.65e-03 | 9 | 129 | 2 | IPR010472 | |
| Domain | GTPase-bd | 1.65e-03 | 9 | 129 | 2 | IPR010473 | |
| Domain | Drf_FH3 | 1.65e-03 | 9 | 129 | 2 | SM01139 | |
| Domain | Drf_GBD | 1.65e-03 | 9 | 129 | 2 | SM01140 | |
| Domain | A2M | 2.05e-03 | 10 | 129 | 2 | PF00207 | |
| Domain | A2M_N_2 | 2.05e-03 | 10 | 129 | 2 | IPR011625 | |
| Domain | A2M_comp | 2.05e-03 | 10 | 129 | 2 | IPR011626 | |
| Domain | A2M_recep | 2.05e-03 | 10 | 129 | 2 | PF07677 | |
| Domain | A2M_comp | 2.05e-03 | 10 | 129 | 2 | PF07678 | |
| Domain | A2M_N | 2.05e-03 | 10 | 129 | 2 | PF01835 | |
| Domain | A2M_N | 2.05e-03 | 10 | 129 | 2 | IPR002890 | |
| Domain | A-macroglobulin_rcpt-bd | 2.05e-03 | 10 | 129 | 2 | IPR009048 | |
| Domain | ALPHA_2_MACROGLOBULIN | 2.05e-03 | 10 | 129 | 2 | PS00477 | |
| Domain | ZU5 | 2.05e-03 | 10 | 129 | 2 | PS51145 | |
| Domain | A2M_N_2 | 2.05e-03 | 10 | 129 | 2 | PF07703 | |
| Domain | Macroglobln_a2 | 2.05e-03 | 10 | 129 | 2 | IPR001599 | |
| Domain | C2 | 2.16e-03 | 131 | 129 | 5 | PF00168 | |
| Domain | KH_1 | 2.28e-03 | 38 | 129 | 3 | PF00013 | |
| Domain | GBD/FH3_dom | 2.50e-03 | 11 | 129 | 2 | IPR014768 | |
| Domain | GBD_FH3 | 2.50e-03 | 11 | 129 | 2 | PS51232 | |
| Domain | SM22_calponin | 2.50e-03 | 11 | 129 | 2 | IPR003096 | |
| Domain | C2 | 2.63e-03 | 137 | 129 | 5 | SM00239 | |
| Domain | KH | 2.64e-03 | 40 | 129 | 3 | SM00322 | |
| Domain | KH_dom | 2.64e-03 | 40 | 129 | 3 | IPR004087 | |
| Domain | ZU5 | 2.99e-03 | 12 | 129 | 2 | PF00791 | |
| Domain | ZU5_dom | 2.99e-03 | 12 | 129 | 2 | IPR000906 | |
| Domain | C2 | 3.07e-03 | 142 | 129 | 5 | PS50004 | |
| Domain | - | 3.66e-03 | 148 | 129 | 5 | 2.60.40.150 | |
| Domain | FH2 | 4.69e-03 | 15 | 129 | 2 | PS51444 | |
| Domain | FH2_Formin | 4.69e-03 | 15 | 129 | 2 | IPR015425 | |
| Domain | FH2 | 4.69e-03 | 15 | 129 | 2 | PF02181 | |
| Domain | FH2 | 4.69e-03 | 15 | 129 | 2 | SM00498 | |
| Domain | C2_dom | 5.64e-03 | 164 | 129 | 5 | IPR000008 | |
| Domain | C345C | 6.02e-03 | 17 | 129 | 2 | SM00643 | |
| Domain | Helicase_C | 6.48e-03 | 107 | 129 | 4 | PF00271 | |
| Domain | HELICc | 6.48e-03 | 107 | 129 | 4 | SM00490 | |
| Domain | Helicase_C | 6.70e-03 | 108 | 129 | 4 | IPR001650 | |
| Domain | Rib_L2_dom2 | 6.74e-03 | 18 | 129 | 2 | IPR014722 | |
| Domain | Terpenoid_cyclase/PrenylTrfase | 6.74e-03 | 18 | 129 | 2 | IPR008930 | |
| Domain | - | 6.74e-03 | 18 | 129 | 2 | 2.30.30.30 | |
| Pathway | REACTOME_HDR_THROUGH_MMEJ_ALT_NHEJ | 7.72e-05 | 12 | 102 | 3 | M27569 | |
| Pathway | REACTOME_HDR_THROUGH_MMEJ_ALT_NHEJ | 7.72e-05 | 12 | 102 | 3 | MM15282 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | FLNA AARS1 GBF1 ILF3 IMPDH2 ATRX TCOF1 AIMP1 DYNC2H1 POLA1 SYNE1 CKAP5 BAZ1B RRBP1 CMYA5 NDUFA10 ADAR DDX1 HNRNPK PRDM2 SEPTIN2 PARP1 ZC3H11A ADSS2 UBAP2L FUBP1 DIAPH1 MPHOSPH8 EIF3H SPEN HSPA5 THRAP3 | 1.52e-15 | 1425 | 140 | 32 | 30948266 |
| Pubmed | FLNA AARS1 ILF3 IMPDH2 TCOF1 AIMP1 CKAP5 ASH2L DDX1 HNRNPK HP1BP3 SEPTIN2 PARP1 ALMS1 UBAP2L DIAPH1 EIF3H HSPA5 CNN2 | 1.57e-13 | 494 | 140 | 19 | 26831064 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | FLNA AARS1 ILF3 IMPDH2 ATRX TCOF1 CKAP5 BAZ1B SPART TACC2 BTAF1 RRBP1 ADAR EMSY HNRNPK HP1BP3 SEPTIN2 PARP1 ZC3H11A FAM193A SMG7 ALMS1 UBAP2L PRRC2C | 4.96e-13 | 934 | 140 | 24 | 33916271 |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | FLNA RC3H2 GBF1 ILF3 POLA1 CKAP5 SPART RRBP1 ADAR HNRNPK SEPTIN2 HAUS8 FAM193A SMG7 UBAP2L PRRC2C RPL22L1 EIF3H SPEN THRAP3 CNN2 | 1.70e-12 | 724 | 140 | 21 | 36232890 |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | FLNA ILF3 ARID4B ATRX BAZ1B RRBP1 NDUFA10 ADAR EMSY DDX1 HNRNPK HP1BP3 PARP1 ZC3H11A BRCA2 UBAP2L PRRC2C FUBP1 SYT1 MPHOSPH8 SPEN HSPA5 THRAP3 | 5.81e-12 | 954 | 140 | 23 | 36373674 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | FLNA GBF1 ILF3 ARID4B HIRIP3 ATRX TCOF1 CKAP5 BAZ1B BTAF1 RRBP1 RFX7 EMSY HNRNPK PRDM2 ZC3H11A UBAP2L FUBP1 LIMCH1 SPEN THRAP3 | 5.96e-12 | 774 | 140 | 21 | 15302935 |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | FOXO1 MIS18BP1 ATRX TCOF1 DYNC2H1 BAZ1B SPART TACC2 CUL7 EMSY DDX1 CDC7 SMG7 ALMS1 BRCA2 PRRC2C DIAPH1 SPEN | 3.11e-11 | 588 | 140 | 18 | 38580884 |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | FLNA AARS1 GBF1 ILF3 IMPDH2 ANK3 TCOF1 AIMP1 CKAP5 SPART SRP19 ADAR ASH2L DDX1 HNRNPK SEPTIN2 PARP1 UBAP2L PRRC2C FUBP1 DIAPH1 LIMCH1 EIF3H HSPA5 | 3.74e-11 | 1149 | 140 | 24 | 35446349 |
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | FLNA ILF3 BAZ1B SPART TACC2 EMSY HNRNPK SEPTIN2 PARP1 ZC3H11A BRCA2 UBAP2L FUBP1 HSPA5 SENP5 | 3.94e-10 | 444 | 140 | 15 | 34795231 |
| Pubmed | FLNA ILF3 ANK3 ACADL MAP6 SYNE1 CKAP5 RRBP1 SUCLG1 FMNL2 ADAM22 OPCML DDX1 HNRNPK HP1BP3 SEPTIN2 PARP1 UBAP2L PRRC2C SYT1 C4A C4B LIMCH1 HSPA5 THRAP3 | 5.83e-10 | 1431 | 140 | 25 | 37142655 | |
| Pubmed | SND1 binds SARS-CoV-2 negative-sense RNA and promotes viral RNA synthesis through NSP9. | ILF3 SYNE1 PABPC1L2A CMYA5 HNRNPK HP1BP3 UBAP2L PRRC2C FUBP1 SPEN THRAP3 CNN2 | 6.77e-10 | 258 | 140 | 12 | 37794589 |
| Pubmed | Oct4 links multiple epigenetic pathways to the pluripotency network. | FLNA ILF3 TCOF1 CKAP5 L1TD1 ASH2L NEDD4 SEPTIN2 PARP1 UBAP2L CNN2 | 7.18e-10 | 203 | 140 | 11 | 22083510 |
| Pubmed | FLNA AARS1 ILF3 IMPDH2 TCOF1 AIMP1 CKAP5 RRBP1 DDX1 HNRNPK HP1BP3 SEPTIN2 PARP1 ZC3H11A UBAP2L FUBP1 EIF3H NFAT5 HSPA5 | 7.36e-10 | 809 | 140 | 19 | 32129710 | |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | FLNA AARS1 GBF1 HIRIP3 IMPDH2 AIMP1 POLA1 TCEAL4 SRP19 UNC13D CMYA5 ZZEF1 DDX1 HNRNPK SEPTIN2 TXNRD1 METTL1 RAB3GAP1 ADSS2 FUBP1 DIAPH1 LIMCH1 EIF3H HSPA5 CNN2 | 8.19e-10 | 1455 | 140 | 25 | 22863883 |
| Pubmed | FLNA ANK3 TCOF1 BAZ1B ADAR ASH2L EMSY HNRNPK ZC3H11A SMG7 ALMS1 UBAP2L PRRC2C SPEN HSPA5 THRAP3 | 8.45e-10 | 549 | 140 | 16 | 38280479 | |
| Pubmed | FLNA AARS1 ILF3 IMPDH2 CKAP5 RRBP1 ADAR DDX1 HNRNPK PARP1 ZC3H11A UBAP2L PRRC2C FUBP1 HSPA5 THRAP3 | 8.90e-10 | 551 | 140 | 16 | 34728620 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | FLNA ILF3 IMPDH2 TCOF1 SYNE1 CKAP5 BAZ1B BTAF1 CUL7 RRBP1 ADAR DDX1 HNRNPK HP1BP3 PARP1 ZC3H11A UBAP2L FUBP1 SPEN HSPA5 THRAP3 | 9.90e-10 | 1024 | 140 | 21 | 24711643 |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | FLNA AARS1 IMPDH2 ATRX AIMP1 POLA1 CKAP5 DDX1 HNRNPK PARP1 ZC3H11A UBAP2L HSPA5 | 1.05e-09 | 332 | 140 | 13 | 32786267 |
| Pubmed | ILF3 IMPDH2 ANK3 TCOF1 MAP6 SYNE1 CKAP5 ARMCX4 ADAM22 EMSY HNRNPK NEDD4 SEPTIN2 PARP1 UBAP2L PRRC2C DIAPH1 SYT1 LIMCH1 THRAP3 | 2.08e-09 | 963 | 140 | 20 | 28671696 | |
| Pubmed | MBD5 and MBD6 stabilize the BAP1 complex and promote BAP1-dependent cancer. | FLNA ILF3 IMPDH2 NDUFA10 EMSY DDX1 HNRNPK HP1BP3 SEPTIN2 PARP1 C4A HSPA5 | 2.26e-09 | 287 | 140 | 12 | 36180891 |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | FLNA AARS1 ILF3 IMPDH2 TCOF1 AIMP1 POLA1 CKAP5 SRP19 TACC2 RRBP1 DDX1 HNRNPK HP1BP3 TXNRD1 PARP1 UBAP2L PRRC2C DIAPH1 RPL22L1 EIF3H HSPA5 THRAP3 CNN2 | 2.41e-09 | 1415 | 140 | 24 | 28515276 |
| Pubmed | TIF1γ inhibits lung adenocarcinoma EMT and metastasis by interacting with the TAF15/TBP complex. | 3.26e-09 | 179 | 140 | 10 | 36261009 | |
| Pubmed | MET Inhibitors Promote Liver Tumor Evasion of the Immune Response by Stabilizing PDL1. | FLNA AARS1 IMPDH2 AIMP1 HNRNPK TXNRD1 PARP1 FUBP1 HSPA5 CNN2 | 3.83e-09 | 182 | 140 | 10 | 30711629 |
| Pubmed | ILF3 IMPDH2 ANK3 TCOF1 CKAP5 SPART FNDC3A RRBP1 DENND4C HNRNPK SEPTIN2 ARFGAP2 PARP1 ADSS2 UBAP2L PRRC2C HSPA5 | 4.46e-09 | 708 | 140 | 17 | 39231216 | |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | FLNA AARS1 ILF3 ANK3 ACADL DYNC2H1 SYNE1 RRBP1 ZZEF1 DDX1 HNRNPK HP1BP3 SEPTIN2 TXNRD1 PARP1 ADSS2 DIAPH1 HSPA5 | 4.77e-09 | 807 | 140 | 18 | 30575818 |
| Pubmed | AARS1 MIS18BP1 ILF3 IMPDH2 ATRX POLA1 TCEAL4 BAZ1B RRBP1 ADAR DDX1 HP1BP3 TXNRD1 PARP1 ZC3H11A ADSS2 FUBP1 DIAPH1 MPHOSPH8 THRAP3 | 4.98e-09 | 1014 | 140 | 20 | 32416067 | |
| Pubmed | Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15. | FLNA AARS1 ILF3 IMPDH2 SYNE1 ADAR DDX1 HNRNPK HP1BP3 PARP1 ZC3H11A UBAP2L PRRC2C FUBP1 EIF3H HSPA5 THRAP3 | 5.05e-09 | 714 | 140 | 17 | 28302793 |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | SEMG2 FLNA AARS1 GBF1 IMPDH2 TCOF1 AIMP1 TCEAL4 CKAP5 SPART SUCLG1 ADAR EMSY HP1BP3 SEPTIN2 TXNRD1 PARP1 ZC3H11A ADSS2 UBAP2L HSPA5 THRAP3 CNN2 | 6.30e-09 | 1367 | 140 | 23 | 32687490 |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | FLNA ILF3 IMPDH2 AIMP1 CKAP5 BAZ1B RRBP1 NDUFA10 ADAR DDX1 HNRNPK HP1BP3 SEPTIN2 PARP1 ZC3H11A PRRC2C RPL22L1 EIF3H SPEN MRPL24 HSPA5 THRAP3 | 6.91e-09 | 1257 | 140 | 22 | 36526897 |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | ILF3 ARID4B HIRIP3 ATRX TCOF1 CKAP5 BAZ1B RRBP1 RFX7 ADAR ASH2L EMSY HNRNPK PRDM2 HP1BP3 PARP1 ZC3H11A ZSCAN30 MPHOSPH8 SPEN HSPA5 THRAP3 | 1.16e-08 | 1294 | 140 | 22 | 30804502 |
| Pubmed | FLNA ILF3 IMPDH2 TCOF1 POLA1 CKAP5 ADAR DDX1 HNRNPK PARP1 LIMCH1 HSPA5 | 1.50e-08 | 340 | 140 | 12 | 24332808 | |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | FLNA ILF3 IMPDH2 TCOF1 AIMP1 BAZ1B RRBP1 NDUFA10 SUCLG1 ADAR EMSY DDX1 HNRNPK HP1BP3 PARP1 UBAP2L FUBP1 DIAPH1 RPL22L1 MRPL24 HSPA5 THRAP3 | 1.61e-08 | 1318 | 140 | 22 | 30463901 |
| Pubmed | FLNA ILF3 RRBP1 ADAR DDX1 HNRNPK PARP1 UBAP2L FUBP1 HSPA5 THRAP3 | 1.64e-08 | 274 | 140 | 11 | 34244482 | |
| Pubmed | 1.74e-08 | 72 | 140 | 7 | 31248990 | ||
| Pubmed | FLNA ILF3 HIRIP3 TCOF1 TACC2 RRBP1 ADAR DENND4C HNRNPK ZC3H11A UBAP2L FUBP1 SPEN THRAP3 | 1.81e-08 | 503 | 140 | 14 | 16964243 | |
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | ILF3 ATRX BAZ1B ADAR EMSY SEPTIN2 PARP1 ZC3H11A FUBP1 SPEN THRAP3 | 2.29e-08 | 283 | 140 | 11 | 30585729 |
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | FLNA RC3H2 ILF3 TCOF1 SYNE1 RRBP1 ADAR DDX1 HNRNPK PARP1 ZC3H11A UBAP2L PRRC2C FUBP1 SPEN THRAP3 NOVA1 | 3.02e-08 | 807 | 140 | 17 | 22681889 |
| Pubmed | FLNA ILF3 TCOF1 AIMP1 RRBP1 DDX1 HNRNPK HP1BP3 PARP1 UBAP2L PRRC2C RPL22L1 EIF3H HSPA5 THRAP3 | 3.12e-08 | 615 | 140 | 15 | 31048545 | |
| Pubmed | FLNA AARS1 GBF1 ILF3 IMPDH2 AIMP1 RRBP1 ASH2L HNRNPK SEPTIN2 PARP1 UBAP2L DIAPH1 HEPHL1 HSPA5 THRAP3 | 3.21e-08 | 711 | 140 | 16 | 33022573 | |
| Pubmed | FLNA ILF3 TCOF1 CKAP5 RRBP1 ADAR HNRNPK HP1BP3 PARP1 PRRC2C FUBP1 | 3.49e-08 | 295 | 140 | 11 | 26209609 | |
| Pubmed | AKAP6 PCP4 AARS1 ANK3 ATRX TCOF1 FOLH1 SYNE1 CKAP5 ARMCX4 RRBP1 CMYA5 NDUFA10 FMNL2 ADAM22 HNRNPK SEPTIN2 PARP1 OTOF HSPA5 PICK1 | 5.08e-08 | 1285 | 140 | 21 | 35914814 | |
| Pubmed | IMPDH2 TCOF1 AIMP1 BAZ1B SRP19 NDUFA10 ADAR DDX1 HNRNPK PARP1 UBAP2L PRRC2C RPL22L1 HSPA5 THRAP3 | 5.36e-08 | 641 | 140 | 15 | 36057605 | |
| Pubmed | Tau interactome maps synaptic and mitochondrial processes associated with neurodegeneration. | FLNA ILF3 ANK3 MAP6 NDUFA10 SUCLG1 DDX1 TXNRD1 PARP1 RAB3GAP1 SCN7A SYT1 RPL22L1 SNCG | 6.53e-08 | 558 | 140 | 14 | 35063084 |
| Pubmed | SEMG2 FLNA ILF3 ATRX TCOF1 BAZ1B ADAR HNRNPK HP1BP3 PARP1 ZC3H11A BRCA2 C4B HSPA5 THRAP3 | 6.68e-08 | 652 | 140 | 15 | 31180492 | |
| Pubmed | ARID4B IMPDH2 ATRX AIMP1 BAZ1B CUL7 RFX7 ASH2L EMSY DDX1 PRDM2 HP1BP3 SMG7 ALMS1 ZFHX4 UBAP2L PRRC2C FUBP1 EIF3H SPEN MRPL24 SENP5 | 6.69e-08 | 1429 | 140 | 22 | 35140242 | |
| Pubmed | FLNA ILF3 TCOF1 AIMP1 SRP19 RRBP1 HNRNPK HP1BP3 FAM193A UBAP2L PRRC2C DIAPH1 HSPA5 THRAP3 SENP5 | 7.09e-08 | 655 | 140 | 15 | 35819319 | |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | FOXO1 GBF1 ARID4B CKAP5 BTAF1 CUL7 RRBP1 ADAR ASH2L EMSY ZC3H11A ZFHX4 PRRC2C SPEN MRPL24 THRAP3 NOVA1 | 7.16e-08 | 857 | 140 | 17 | 25609649 |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | ARID4B IMPDH2 AIMP1 CKAP5 BAZ1B TACC2 CUL7 RRBP1 ADAR DDX1 HNRNPK HP1BP3 ZC3H11A UBAP2L PRRC2C EIF3H | 7.85e-08 | 759 | 140 | 16 | 35915203 |
| Pubmed | AKAP6 FLNA ANK3 ATRX MAP6 PHTF2 BAZ1B UNC13D TACC2 ASH2L HNRNPK PRDM2 ZC3H11A UBAP2L UNC5C DIAPH1 SYT1 NFAT5 LRRC71 | 7.99e-08 | 1084 | 140 | 19 | 11544199 | |
| Pubmed | ILF3 TCOF1 AIMP1 SPART SEPTIN2 PARP1 ZC3H11A UBAP2L PRRC2C FUBP1 EIF3H THRAP3 | 8.59e-08 | 399 | 140 | 12 | 35987950 | |
| Pubmed | TXLNA enhances TBK1 phosphorylation by suppressing PPM1B recruitment. | 9.63e-08 | 138 | 140 | 8 | 37506885 | |
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | FLNA TCOF1 CKAP5 RRBP1 DENND4C UBAP2L PRRC2C LIMCH1 USP1 CNN2 | 9.72e-08 | 256 | 140 | 10 | 33397691 |
| Pubmed | FLNA AARS1 ILF3 IMPDH2 CKAP5 SRP19 ADAR EMSY DDX1 HNRNPK PRDM2 SEPTIN2 TXNRD1 PARP1 ZC3H11A PRRC2C FUBP1 SPEN THRAP3 | 1.05e-07 | 1103 | 140 | 19 | 34189442 | |
| Pubmed | FLNA ILF3 IMPDH2 CKAP5 DDX1 HNRNPK PARP1 ZC3H11A UBAP2L PRRC2C HSPA5 | 1.09e-07 | 330 | 140 | 11 | 32529326 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | FLNA AARS1 MIS18BP1 ILF3 IMPDH2 POLA1 CKAP5 BAZ1B RRBP1 ADAR DDX1 HNRNPK PARP1 RAB3GAP1 ZC3H11A ADSS2 FUBP1 DIAPH1 RPL22L1 HSPA5 THRAP3 | 1.20e-07 | 1353 | 140 | 21 | 29467282 |
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | ILF3 IMPDH2 TCOF1 POLA1 BAZ1B BTAF1 EMSY HP1BP3 FUBP1 SPEN THRAP3 | 1.51e-07 | 341 | 140 | 11 | 32971831 |
| Pubmed | LCP1 preferentially binds clasped αMβ2 integrin and attenuates leukocyte adhesion under flow. | FLNA AARS1 ILF3 IMPDH2 CKAP5 SUCLG1 HNRNPK SEPTIN2 PARP1 UBAP2L DIAPH1 | 1.65e-07 | 344 | 140 | 11 | 30333137 |
| Pubmed | Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing. | 1.65e-07 | 271 | 140 | 10 | 32433965 | |
| Pubmed | HIV-1 Vpr induces cell cycle arrest and enhances viral gene expression by depleting CCDC137. | 1.65e-07 | 148 | 140 | 8 | 32538781 | |
| Pubmed | 2.52e-07 | 216 | 140 | 9 | 31519766 | ||
| Pubmed | TCAF2 FLNA TCOF1 AIMP1 BTAF1 RRBP1 EMSY HNRNPK PRRC2C FUBP1 CNN2 | 2.59e-07 | 360 | 140 | 11 | 33111431 | |
| Pubmed | Molecular Characterization of the Oncogene BTF3 and Its Targets in Colorectal Cancer. | FLNA ILF3 IMPDH2 TCOF1 RRBP1 ADAR DDX1 HNRNPK PARP1 UBAP2L MPHOSPH8 NFAT5 HSPA5 THRAP3 | 2.64e-07 | 626 | 140 | 14 | 33644029 |
| Pubmed | 2.86e-07 | 159 | 140 | 8 | 31332168 | ||
| Pubmed | GBF1 ILF3 IMPDH2 ANK3 TCOF1 AIMP1 SRP19 CUL7 RRBP1 HP1BP3 PARP1 BRCA2 FUBP1 SENP5 | 3.07e-07 | 634 | 140 | 14 | 34591612 | |
| Pubmed | FLNA GBF1 ILF3 AIMP1 POLA1 CKAP5 ADAR DDX1 HNRNPK SEPTIN2 PARP1 DIAPH1 EIF3H HSPA5 | 3.31e-07 | 638 | 140 | 14 | 33239621 | |
| Pubmed | FLNA ILF3 ATRX SYNE1 SPEF2 RRBP1 DDX1 HP1BP3 PARP1 BMPR1B PRRC2C FUBP1 UNC5C MPHOSPH8 LIMCH1 POLQ SPEN USP1 HSPA5 THRAP3 PICK1 | 3.43e-07 | 1442 | 140 | 21 | 35575683 | |
| Pubmed | New roles for the de-ubiquitylating enzyme OTUD4 in an RNA-protein network and RNA granules. | ILF3 AIMP1 RRBP1 ADAR ADAM22 ZC3H11A FAM193A UBAP2L PRRC2C FUBP1 EIF3H THRAP3 | 4.12e-07 | 462 | 140 | 12 | 31138677 |
| Pubmed | RC3H2 AARS1 IMPDH2 ATRX BTAF1 RRBP1 ZZEF1 ASH2L DDX1 HP1BP3 ARFGAP2 PRRC2C C4A C4B | 4.14e-07 | 650 | 140 | 14 | 38777146 | |
| Pubmed | FLNA ILF3 ARID4B TCOF1 CKAP5 BAZ1B BTAF1 RRBP1 APLF HNRNPK TXNRD1 PARP1 ZC3H11A UBAP2L PRRC2C RPL22L1 HSPA5 | 4.14e-07 | 971 | 140 | 17 | 33306668 | |
| Pubmed | FLNA AARS1 GBF1 CKAP5 SPART FNDC3A RRBP1 ARFGAP2 RAB3GAP1 UBAP2L PRRC2C LIMCH1 CNN2 | 5.56e-07 | 568 | 140 | 13 | 37774976 | |
| Pubmed | Cellular RNA binding proteins NS1-BP and hnRNP K regulate influenza A virus RNA splicing. | 5.78e-07 | 40 | 140 | 5 | 23825951 | |
| Pubmed | FLNA RC3H2 GBF1 ILF3 TCOF1 AIMP1 SRP19 RRBP1 NDUFA10 SUCLG1 FMNL2 FABP1 HP1BP3 PARP1 UBAP2L PRRC2C C4B LIMCH1 THRAP3 CNN2 | 6.56e-07 | 1371 | 140 | 20 | 36244648 | |
| Pubmed | SEMG2 FLNA TCOF1 AIMP1 RRBP1 DDX1 HNRNPK PARP1 PRRC2C DIAPH1 HSPA5 CNN2 | 7.33e-07 | 488 | 140 | 12 | 31324722 | |
| Pubmed | 8.86e-07 | 251 | 140 | 9 | 31076518 | ||
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | FOXO1 HIRIP3 TCOF1 SRP19 ASH2L DENND4C HP1BP3 CDC7 SEPTIN2 HAUS8 ARFGAP2 SMG7 UBAP2L LIMCH1 EIF3H UVRAG THRAP3 | 1.04e-06 | 1038 | 140 | 17 | 26673895 |
| Pubmed | Tissue-Specific Regulation of the Wnt/β-Catenin Pathway by PAGE4 Inhibition of Tankyrase. | 1.04e-06 | 256 | 140 | 9 | 32698014 | |
| Pubmed | FLNA AARS1 ILF3 IMPDH2 CKAP5 DDX1 HNRNPK SEPTIN2 PARP1 UBAP2L FUBP1 DIAPH1 HSPA5 CNN2 | 1.12e-06 | 707 | 140 | 14 | 19738201 | |
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | ILF3 TCOF1 BAZ1B ADAR DDX1 HNRNPK HP1BP3 PARP1 ZFHX4 PRRC2C SPEN HSPA5 THRAP3 | 1.12e-06 | 605 | 140 | 13 | 28977666 |
| Pubmed | 1.19e-06 | 260 | 140 | 9 | 36199071 | ||
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | MIS18BP1 ARID4B HIRIP3 ATRX POLA1 BAZ1B BTAF1 EMSY PRDM2 HP1BP3 PARP1 MPHOSPH8 SPEN | 1.19e-06 | 608 | 140 | 13 | 36089195 |
| Pubmed | FLNA ILF3 AIMP1 SPART RRBP1 NDUFA10 ADAR DDX1 HNRNPK HP1BP3 PARP1 UBAP2L PRRC2C HSPA5 | 1.50e-06 | 725 | 140 | 14 | 27025967 | |
| Pubmed | ISG15 Connects Autophagy and IFN-γ-Dependent Control of Toxoplasma gondii Infection in Human Cells. | 1.52e-06 | 268 | 140 | 9 | 33024031 | |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 1.75e-06 | 202 | 140 | 8 | 33005030 | |
| Pubmed | 1.75e-06 | 202 | 140 | 8 | 24639526 | ||
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | FLNA ILF3 AIMP1 CKAP5 ADAR DDX1 HNRNPK NEDD4 SEPTIN2 PARP1 PRRC2C FUBP1 EIF3H HSPA5 THRAP3 | 1.81e-06 | 847 | 140 | 15 | 35235311 |
| Pubmed | FLNA ILF3 ATRX TCOF1 CKAP5 ADAR HNRNPK HP1BP3 PARP1 ZC3H11A HSPA5 | 1.88e-06 | 441 | 140 | 11 | 31239290 | |
| Pubmed | MKRN2 Physically Interacts with GLE1 to Regulate mRNA Export and Zebrafish Retinal Development. | RC3H2 ATRX TCOF1 AIMP1 DYNC2H1 CKAP5 BMPR1B ZC3H11A UNC5C THRAP3 | 2.07e-06 | 358 | 140 | 10 | 32460013 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | FOXO1 USP53 AARS1 GBF1 CKAP5 RFX7 DENND4C DDX1 NEDD4 HAUS8 ARFGAP2 ALMS1 PRRC2C LIMCH1 UVRAG | 2.21e-06 | 861 | 140 | 15 | 36931259 |
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | 2.23e-06 | 361 | 140 | 10 | 26167880 | |
| Pubmed | MIS18BP1 ARID4B HIRIP3 CKAP5 SPART DENND4C HAUS8 ALMS1 UBAP2L DIAPH1 MPHOSPH8 SPEN THRAP3 | 2.27e-06 | 645 | 140 | 13 | 25281560 | |
| Pubmed | AARS1 ILF3 CMYA5 SUCLG1 ADAR DDX1 HNRNPK HP1BP3 PARP1 FUBP1 HSPA5 | 2.34e-06 | 451 | 140 | 11 | 36168627 | |
| Pubmed | FLNA RC3H2 HIRIP3 TCOF1 DYNC2H1 TCEAL4 SYNE1 BAZ1B FNDC3A ARFGAP2 PARP1 BRCA2 FUBP1 LIMCH1 | 2.36e-06 | 754 | 140 | 14 | 35906200 | |
| Pubmed | HEY1 functions are regulated by its phosphorylation at Ser-68. | 2.47e-06 | 95 | 140 | 6 | 27129302 | |
| Pubmed | 2.59e-06 | 286 | 140 | 9 | 32041737 | ||
| Pubmed | FLNA ILF3 AIMP1 BAZ1B SPART BTAF1 ADAR DDX1 HNRNPK SEPTIN2 PARP1 EIF3H HSPA5 | 2.60e-06 | 653 | 140 | 13 | 33742100 | |
| Pubmed | FLNA AARS1 IMPDH2 TCOF1 POLA1 CKAP5 BAZ1B CUL7 HP1BP3 ZC3H11A UBAP2L PRRC2C SPEN | 2.60e-06 | 653 | 140 | 13 | 22586326 | |
| Pubmed | FLNA GBF1 IMPDH2 CKAP5 SRP19 BTAF1 RRBP1 ZZEF1 HNRNPK UBAP2L EIF3H HSPA5 THRAP3 | 2.78e-06 | 657 | 140 | 13 | 36180527 | |
| Pubmed | RC3H2 ATRX L1TD1 ASH2L HAUS8 ZC3H11A ALMS1 UBAP2L PRRC2C EIF3H SPEN | 3.40e-06 | 469 | 140 | 11 | 27634302 | |
| Pubmed | FLNA ANK3 ACADL AIMP1 MAP6 CKAP5 TACC2 RRBP1 NDUFA10 SUCLG1 ADAM22 ARFGAP2 RAB3GAP1 UBAP2L PRRC2C SYT1 THRAP3 | 3.60e-06 | 1139 | 140 | 17 | 36417873 | |
| Pubmed | 3.62e-06 | 298 | 140 | 9 | 30737378 | ||
| Interaction | YAP1 interactions | FOXO1 FLNA GBF1 IMPDH2 ANK3 TCOF1 CKAP5 BAZ1B RRBP1 ADAR ASH2L DDX1 HNRNPK NEDD4 SEPTIN2 PARP1 ZC3H11A ADSS2 UBAP2L PRRC2C FUBP1 EIF3H SPEN NFAT5 HSPA5 UVRAG THRAP3 CNN2 | 7.20e-10 | 1095 | 135 | 28 | int:YAP1 |
| Interaction | CEBPB interactions | FOXO1 FLNA AARS1 ILF3 IMPDH2 TCOF1 AIMP1 POLA1 BAZ1B SPART RRBP1 NDUFA10 SUCLG1 ADAR ASH2L DDX1 HNRNPK HP1BP3 SEPTIN2 PARP1 ZC3H11A BRCA2 UBAP2L PRRC2C FUBP1 RPL22L1 EIF3H NFAT5 HSPA5 THRAP3 CNN2 | 5.01e-09 | 1443 | 135 | 31 | int:CEBPB |
| Interaction | NAA40 interactions | FLNA AARS1 ILF3 IMPDH2 ATRX TCOF1 CKAP5 BAZ1B SPART TACC2 BTAF1 RRBP1 ADAR EMSY HNRNPK HP1BP3 SEPTIN2 PARP1 ZC3H11A FAM193A SMG7 ALMS1 UBAP2L PRRC2C LIMCH1 | 6.89e-09 | 978 | 135 | 25 | int:NAA40 |
| Interaction | BIRC3 interactions | FLNA AARS1 ILF3 IMPDH2 TCOF1 AIMP1 DYNC2H1 SYNE1 CKAP5 BAZ1B RRBP1 CMYA5 NDUFA10 ADAR DDX1 HNRNPK PRDM2 SEPTIN2 PARP1 ZC3H11A ADSS2 UBAP2L FUBP1 DIAPH1 MPHOSPH8 EIF3H SPEN HSPA5 THRAP3 | 1.35e-08 | 1334 | 135 | 29 | int:BIRC3 |
| Interaction | KCNA3 interactions | CHL1 ILF3 IMPDH2 ANK3 TCOF1 SPEF2 CKAP5 SPART FNDC3A RRBP1 DENND4C HNRNPK PRDM2 CDC7 SEPTIN2 ARFGAP2 PARP1 ADSS2 UBAP2L PRRC2C POLQ SPEN HSPA5 | 1.66e-08 | 871 | 135 | 23 | int:KCNA3 |
| Interaction | TOP1 interactions | FOXO1 ILF3 ARID4B TCOF1 POLA1 CKAP5 BAZ1B CUL7 ADAR APLF HNRNPK HP1BP3 PARP1 ZC3H11A BRCA2 DIAPH1 MPHOSPH8 EIF3H THRAP3 | 2.02e-07 | 696 | 135 | 19 | int:TOP1 |
| Interaction | SMC5 interactions | FLNA ILF3 ARID4B ATRX BAZ1B RRBP1 NDUFA10 ADAR EMSY DDX1 HNRNPK HP1BP3 PARP1 ZC3H11A BRCA2 UBAP2L PRRC2C FUBP1 SYT1 MPHOSPH8 SPEN HSPA5 THRAP3 | 2.03e-07 | 1000 | 135 | 23 | int:SMC5 |
| Interaction | XRCC5 interactions | FOXO1 USP53 RC3H2 ILF3 ATRX POLA1 FNDC3A CUL7 ZZEF1 ADAR APLF PARP1 BRCA2 FUBP1 DIAPH1 UVRAG | 3.69e-07 | 515 | 135 | 16 | int:XRCC5 |
| Interaction | SUMO2 interactions | FLNA AARS1 IMPDH2 ATRX AIMP1 POLA1 CKAP5 BAZ1B DDX1 HNRNPK HP1BP3 NEDD4 PARP1 ZC3H11A UBAP2L HSPA5 SENP5 | 4.56e-07 | 591 | 135 | 17 | int:SUMO2 |
| Interaction | BAP1 interactions | FOXO1 FLNA AARS1 GBF1 ILF3 IMPDH2 ANK3 TCOF1 AIMP1 CKAP5 SPART SRP19 ADAR ASH2L DDX1 HNRNPK SEPTIN2 PARP1 BRCA2 UBAP2L PRRC2C FUBP1 DIAPH1 LIMCH1 EIF3H HSPA5 | 5.41e-07 | 1314 | 135 | 26 | int:BAP1 |
| Interaction | GUSBP5 interactions | 7.03e-07 | 75 | 135 | 7 | int:GUSBP5 | |
| Interaction | BRCA1 interactions | FLNA AARS1 GBF1 ILF3 IMPDH2 TCOF1 AIMP1 CKAP5 ASH2L EMSY DDX1 HNRNPK HP1BP3 SEPTIN2 PARP1 ZC3H11A SMG7 ALMS1 BRCA2 UBAP2L FUBP1 DIAPH1 EIF3H HSPA5 CNN2 | 7.53e-07 | 1249 | 135 | 25 | int:BRCA1 |
| Interaction | RBM14 interactions | FOXO1 RC3H2 GBF1 ILF3 ATRX CUL7 ADAR HNRNPK HP1BP3 NEDD4 PARP1 BRCA2 FUBP1 SYT1 HSPA5 THRAP3 | 9.44e-07 | 553 | 135 | 16 | int:RBM14 |
| Interaction | EED interactions | CHL1 FLNA AARS1 ILF3 ARID4B IMPDH2 TCOF1 CKAP5 BAZ1B CUL7 ADAR DDX1 HNRNPK PRDM2 HP1BP3 NEDD4 ARFGAP2 PARP1 RAB3GAP1 ZC3H11A FUBP1 LIMCH1 RPL22L1 EIF3H SPEN HSPA5 THRAP3 | 9.62e-07 | 1445 | 135 | 27 | int:EED |
| Interaction | ISG15 interactions | FLNA AARS1 ILF3 AIMP1 DDX1 HNRNPK HP1BP3 NEDD4 SEPTIN2 TXNRD1 PARP1 UBAP2L PRRC2C LIMCH1 THRAP3 | 1.16e-06 | 494 | 135 | 15 | int:ISG15 |
| Interaction | ACE2 interactions | USP53 FLNA ILF3 IMPDH2 TCOF1 AIMP1 TCEAL4 CKAP5 BAZ1B SRP19 NDUFA10 ADAR DDX1 HNRNPK HP1BP3 NEDD4 PARP1 UBAP2L PRRC2C UNC5C RPL22L1 HSPA5 THRAP3 | 1.17e-06 | 1106 | 135 | 23 | int:ACE2 |
| Interaction | NPM1 interactions | FLNA RC3H2 ILF3 IMPDH2 ANK3 BAZ1B SRP19 CUL7 RRBP1 ADAR DDX1 HP1BP3 PARP1 BRCA2 PRRC2C FUBP1 UNC5C LIMCH1 RPL22L1 EIF3H MRPL24 HSPA5 UVRAG SENP5 | 1.34e-06 | 1201 | 135 | 24 | int:NPM1 |
| Interaction | BTF3 interactions | FLNA ILF3 IMPDH2 ANK3 TCOF1 POLA1 CKAP5 SRP19 RRBP1 ADAR DDX1 HNRNPK PARP1 UBAP2L MPHOSPH8 LIMCH1 NFAT5 HSPA5 THRAP3 | 1.61e-06 | 799 | 135 | 19 | int:BTF3 |
| Interaction | BMI1 interactions | ILF3 ATRX SYNE1 PABPC1L2A BAZ1B RRBP1 TDRD1 ADAR HP1BP3 PARP1 ZC3H11A UBAP2L PRRC2C MPHOSPH8 EIF3H SPEN THRAP3 | 2.03e-06 | 659 | 135 | 17 | int:BMI1 |
| Interaction | H3C1 interactions | ARID4B ANK3 ATRX DYNC2H1 POLA1 SYNE1 BAZ1B RRBP1 ZZEF1 ASH2L HNRNPK PRDM2 HP1BP3 PARP1 ADSS2 PRRC2C MPHOSPH8 ADAMTS14 SPEN THRAP3 | 2.40e-06 | 901 | 135 | 20 | int:H3C1 |
| Interaction | PHLPP1 interactions | FLNA TCOF1 CKAP5 RRBP1 CMYA5 DENND4C NEDD4 UBAP2L PRRC2C LIMCH1 USP1 CNN2 | 2.56e-06 | 333 | 135 | 12 | int:PHLPP1 |
| Interaction | FXR1 interactions | FLNA RC3H2 ILF3 IMPDH2 TCOF1 TACC2 CUL7 DDX1 HNRNPK CDC7 NEDD4 SEPTIN2 SMG7 UBAP2L PRRC2C FUBP1 THRAP3 | 3.03e-06 | 679 | 135 | 17 | int:FXR1 |
| Interaction | FMR1 interactions | RC3H2 ILF3 TCOF1 CKAP5 TACC2 ADAR EMSY DDX1 NEDD4 SMG7 UBAP2L PRRC2C FUBP1 THRAP3 PICK1 | 3.18e-06 | 536 | 135 | 15 | int:FMR1 |
| Interaction | XRCC6 interactions | RC3H2 ILF3 ATRX BAZ1B CUL7 ADAR APLF EMSY HNRNPK SEPTIN2 PARP1 ZC3H11A BRCA2 FUBP1 DIAPH1 EIF3H SPEN HSPA5 UVRAG THRAP3 | 3.74e-06 | 928 | 135 | 20 | int:XRCC6 |
| Interaction | PRMT1 interactions | FLNA AARS1 GBF1 ILF3 IMPDH2 CKAP5 CUL7 RRBP1 ADAR ASH2L DDX1 HNRNPK METTL1 PARP1 ZC3H11A UBAP2L PRRC2C FUBP1 HSPA5 THRAP3 | 3.80e-06 | 929 | 135 | 20 | int:PRMT1 |
| Interaction | RAD51AP1 interactions | 4.00e-06 | 36 | 135 | 5 | int:RAD51AP1 | |
| Interaction | KIF5B interactions | FLNA GBF1 IMPDH2 L1TD1 SPART TACC2 CUL7 RRBP1 ASH2L DIAPH1 HSPA5 CNN2 | 4.02e-06 | 348 | 135 | 12 | int:KIF5B |
| Interaction | S100A2 interactions | PCP4 ILF3 ARID4B IMPDH2 AIMP1 SYNE1 CKAP5 ADAR TXNRD1 HAUS8 HSPA5 PICK1 SENP5 | 4.14e-06 | 412 | 135 | 13 | int:S100A2 |
| Interaction | BTRC interactions | FLNA GBF1 ILF3 IMPDH2 TCOF1 CKAP5 PHTF2 ADAR DDX1 HNRNPK NEDD4 PARP1 SMG7 ALMS1 UBAP2L MRPL24 HSPA5 THRAP3 | 4.32e-06 | 775 | 135 | 18 | int:BTRC |
| Interaction | SMURF2 interactions | 4.41e-06 | 185 | 135 | 9 | int:SMURF2 | |
| Interaction | GSK3B interactions | FOXO1 FLNA RC3H2 AARS1 IMPDH2 AIMP1 RRBP1 DENND4C HNRNPK TXNRD1 PARP1 FAM193A SMG7 ALMS1 PRRC2C FUBP1 HSPA5 CNN2 PICK1 | 5.38e-06 | 868 | 135 | 19 | int:GSK3B |
| Interaction | RBM39 interactions | FLNA RC3H2 AARS1 ILF3 IMPDH2 ATRX SYNE1 CUL7 ADAR DDX1 HNRNPK HP1BP3 SEPTIN2 PARP1 ZC3H11A UBAP2L PRRC2C FUBP1 EIF3H HSPA5 THRAP3 | 5.90e-06 | 1042 | 135 | 21 | int:RBM39 |
| Interaction | HSP90AB1 interactions | FLNA RC3H2 AARS1 GBF1 ANK3 POLA1 SPEF2 CKAP5 FNDC3A CUL7 RRBP1 NEDD4 TXNRD1 ARFGAP2 PARP1 BRCA2 PRRC2C EIF3H SPEN HSPA5 | 6.20e-06 | 960 | 135 | 20 | int:HSP90AB1 |
| Interaction | NCL interactions | FOXO1 FLNA RC3H2 ILF3 ARID4B SPART SRP19 FNDC3A CUL7 RRBP1 ADAR HNRNPK PARP1 BRCA2 SYT1 EIF3H HSPA5 THRAP3 | 6.47e-06 | 798 | 135 | 18 | int:NCL |
| Interaction | CAPZB interactions | FOXO1 FLNA RC3H2 IMPDH2 AIMP1 SPART SRP19 TACC2 CUL7 RRBP1 ADAR DDX1 HNRNPK CDC7 NEDD4 PARP1 UBAP2L PRRC2C EIF3H FYB1 HSPA5 | 6.54e-06 | 1049 | 135 | 21 | int:CAPZB |
| Interaction | OBSL1 interactions | FLNA ILF3 TCOF1 AIMP1 SYNE1 BAZ1B CUL7 ADAR DDX1 HNRNPK HP1BP3 PARP1 ZC3H11A UBAP2L FUBP1 POLQ SPEN HSPA5 THRAP3 | 9.28e-06 | 902 | 135 | 19 | int:OBSL1 |
| Interaction | HDAC4 interactions | ILF3 ARID4B ATRX CUL7 SUCLG1 DENND4C HNRNPK SEPTIN2 PARP1 FAM193A UBAP2L PRRC2C DIAPH1 LIMCH1 HSPA5 THRAP3 PICK1 | 1.01e-05 | 744 | 135 | 17 | int:HDAC4 |
| Interaction | LRRC31 interactions | 1.01e-05 | 205 | 135 | 9 | int:LRRC31 | |
| Interaction | CIT interactions | FLNA AARS1 ILF3 IMPDH2 TCOF1 DYNC2H1 SYNE1 CKAP5 BAZ1B CUL7 CMYA5 ZZEF1 ADAR DDX1 HNRNPK HP1BP3 ALMS1 UBAP2L PRRC2C MPHOSPH8 EIF3H GRAMD1C HSPA5 THRAP3 CNN2 | 1.07e-05 | 1450 | 135 | 25 | int:CIT |
| Interaction | GLDC interactions | FLNA ILF3 RRBP1 ADAR DDX1 HNRNPK PARP1 UBAP2L FUBP1 HSPA5 THRAP3 | 1.09e-05 | 321 | 135 | 11 | int:GLDC |
| Interaction | RBMS1 interactions | 1.09e-05 | 207 | 135 | 9 | int:RBMS1 | |
| Interaction | PCBP1 interactions | FLNA RC3H2 ILF3 IMPDH2 CUL7 DDX1 HNRNPK SEPTIN2 PARP1 ADSS2 UBAP2L FUBP1 SNCG HSPA5 THRAP3 NOVA1 | 1.11e-05 | 671 | 135 | 16 | int:PCBP1 |
| Interaction | MKRN2 interactions | RC3H2 ATRX DYNC2H1 PARP1 BMPR1B ZC3H11A SMG7 ALMS1 UBAP2L PRRC2C UNC5C THRAP3 | 1.12e-05 | 385 | 135 | 12 | int:MKRN2 |
| Interaction | CALD1 interactions | FLNA GBF1 ARID4B CUL7 FMNL2 PARP1 PRRC2C ARHGAP28 EIF3H HSPA5 | 1.22e-05 | 265 | 135 | 10 | int:CALD1 |
| Interaction | SCARNA22 interactions | 1.47e-05 | 118 | 135 | 7 | int:SCARNA22 | |
| Interaction | AGR2 interactions | FLNA AARS1 ILF3 IMPDH2 ANK3 ACADL DYNC2H1 SYNE1 RRBP1 ZZEF1 DDX1 HNRNPK HP1BP3 SEPTIN2 TXNRD1 PARP1 ADSS2 DIAPH1 HSPA5 | 1.51e-05 | 934 | 135 | 19 | int:AGR2 |
| Interaction | HDLBP interactions | FLNA GBF1 ILF3 TCOF1 AIMP1 SRP19 RRBP1 NDUFA10 SUCLG1 ADAR FMNL2 FABP1 PARP1 UBAP2L GLRB LIMCH1 EIF3H THRAP3 | 1.64e-05 | 855 | 135 | 18 | int:HDLBP |
| Interaction | MAPT interactions | FOXO1 FLNA AARS1 ILF3 ANK3 MAP6 CKAP5 NDUFA10 SUCLG1 ADAM22 DDX1 HNRNPK TXNRD1 PARP1 RAB3GAP1 UBAP2L SCN7A SYT1 RPL22L1 SNCG HSPA5 | 1.74e-05 | 1119 | 135 | 21 | int:MAPT |
| Interaction | RBM8A interactions | ILF3 SRP19 RRBP1 HNRNPK NEDD4 METTL1 PARP1 ZC3H11A SMG7 PRRC2C FUBP1 EIF3H THRAP3 | 1.81e-05 | 473 | 135 | 13 | int:RBM8A |
| Interaction | NSD2 interactions | 1.84e-05 | 278 | 135 | 10 | int:NSD2 | |
| Interaction | CSNK2A2 interactions | ARID4B HIRIP3 ATRX TCOF1 SPART ASH2L EMSY CDC7 PARP1 SMG7 PRRC2C EIF3H GRAMD1C HSPA5 THRAP3 PICK1 | 2.55e-05 | 718 | 135 | 16 | int:CSNK2A2 |
| Interaction | DDX21 interactions | FOXO1 RC3H2 ILF3 FOLH1 BAZ1B CUL7 ADAR HNRNPK HP1BP3 PARP1 ZC3H11A PRRC2C FUBP1 EIF3H NFAT5 THRAP3 | 2.55e-05 | 718 | 135 | 16 | int:DDX21 |
| Interaction | SERBP1 interactions | FOXO1 FLNA RC3H2 AARS1 ILF3 IMPDH2 ATRX TCOF1 CKAP5 SPART SRP19 FNDC3A RRBP1 SUCLG1 HNRNPK SMG7 ADSS2 UBAP2L PRRC2C FUBP1 EIF3H MRPL24 HSPA5 PICK1 | 2.62e-05 | 1432 | 135 | 24 | int:SERBP1 |
| Interaction | HCFC1 interactions | USP53 RRBP1 ADAR ASH2L TXNRD1 UBAP2L PRRC2C MPHOSPH8 HSPA5 SENP5 | 2.88e-05 | 293 | 135 | 10 | int:HCFC1 |
| Interaction | IVNS1ABP interactions | 2.93e-05 | 180 | 135 | 8 | int:IVNS1ABP | |
| Interaction | HECTD1 interactions | ARID4B IMPDH2 AIMP1 TCEAL4 CKAP5 BAZ1B TACC2 CUL7 RRBP1 ADAR DDX1 HNRNPK HP1BP3 PARP1 ZC3H11A UBAP2L PRRC2C EIF3H UVRAG | 3.10e-05 | 984 | 135 | 19 | int:HECTD1 |
| Interaction | EFTUD2 interactions | FLNA ILF3 IMPDH2 TCOF1 AIMP1 POLA1 CKAP5 SRP19 TACC2 CUL7 RRBP1 DDX1 HNRNPK HP1BP3 TXNRD1 PARP1 UBAP2L PRRC2C DIAPH1 RPL22L1 EIF3H HSPA5 THRAP3 CNN2 | 3.17e-05 | 1449 | 135 | 24 | int:EFTUD2 |
| Interaction | PLS3 interactions | 3.20e-05 | 237 | 135 | 9 | int:PLS3 | |
| Interaction | DDX6 interactions | ILF3 SRP19 CUL7 RRBP1 DDX1 TXNRD1 PARP1 SMG7 UBAP2L PRRC2C FUBP1 EIF3H PICK1 | 3.42e-05 | 503 | 135 | 13 | int:DDX6 |
| Interaction | HNRNPDL interactions | MTG1 RC3H2 ILF3 CUL7 RRBP1 ADAR DDX1 HNRNPK UBAP2L PRRC2C HSPA5 | 3.49e-05 | 364 | 135 | 11 | int:HNRNPDL |
| Interaction | CAPZA1 interactions | FOXO1 FLNA RC3H2 GBF1 IMPDH2 CUL7 HNRNPK NEDD4 PARP1 LIMCH1 HSPA5 | 3.66e-05 | 366 | 135 | 11 | int:CAPZA1 |
| Interaction | STIP1 interactions | FOXO1 FLNA GBF1 ILF3 AIMP1 POLA1 CKAP5 CUL7 ADAR DENND4C DDX1 HNRNPK SEPTIN2 TXNRD1 PARP1 ADSS2 DIAPH1 EIF3H HSPA5 | 4.19e-05 | 1006 | 135 | 19 | int:STIP1 |
| Interaction | H3-3A interactions | ARID4B HIRIP3 ATRX POLA1 CKAP5 BAZ1B BTAF1 EMSY HNRNPK PRDM2 HP1BP3 NEDD4 PARP1 MPHOSPH8 SPEN THRAP3 | 4.23e-05 | 749 | 135 | 16 | int:H3-3A |
| Interaction | BPIFB6 interactions | 4.45e-05 | 2 | 135 | 2 | int:BPIFB6 | |
| Interaction | TARDBP interactions | RC3H2 ILF3 FNDC3A CUL7 RRBP1 ADAR DDX1 HNRNPK ZC3H11A ADSS2 PRRC2C EIF3H HSPA5 | 4.81e-05 | 520 | 135 | 13 | int:TARDBP |
| Interaction | KCTD13 interactions | FLNA ILF3 ANK3 ACADL MAP6 SYNE1 CKAP5 RRBP1 SUCLG1 FMNL2 ADAM22 OPCML DDX1 HNRNPK HP1BP3 SEPTIN2 PARP1 UBAP2L PRRC2C SYT1 LIMCH1 HSPA5 THRAP3 | 5.04e-05 | 1394 | 135 | 23 | int:KCTD13 |
| Interaction | CUL7 interactions | FLNA ILF3 IMPDH2 TCOF1 BAZ1B CUL7 RRBP1 ADAR DDX1 HNRNPK HP1BP3 PARP1 ZC3H11A FUBP1 SPEN HSPA5 THRAP3 | 5.08e-05 | 845 | 135 | 17 | int:CUL7 |
| Interaction | AURKB interactions | FLNA RC3H2 AARS1 GBF1 IMPDH2 TCEAL4 CUL7 CMYA5 ZZEF1 ASH2L DDX1 HNRNPK PARP1 BRCA2 PRRC2C HSPA5 | 5.11e-05 | 761 | 135 | 16 | int:AURKB |
| Interaction | STMN1 interactions | 5.17e-05 | 195 | 135 | 8 | int:STMN1 | |
| Interaction | EEF1A1 interactions | FLNA RC3H2 ILF3 FNDC3A CUL7 RRBP1 ADAR DDX1 HNRNPK SEPTIN2 ADSS2 PRRC2C EIF3H HSPA5 UVRAG THRAP3 | 5.19e-05 | 762 | 135 | 16 | int:EEF1A1 |
| Interaction | PAGE4 interactions | 5.31e-05 | 253 | 135 | 9 | int:PAGE4 | |
| Interaction | FOXL1 interactions | 5.36e-05 | 196 | 135 | 8 | int:FOXL1 | |
| Interaction | NDN interactions | FOXO1 FLNA ILF3 IMPDH2 CKAP5 DDX1 HNRNPK PARP1 ZC3H11A UBAP2L PRRC2C HSPA5 | 5.49e-05 | 453 | 135 | 12 | int:NDN |
| Interaction | DAZL interactions | 5.55e-05 | 145 | 135 | 7 | int:DAZL | |
| Interaction | PHIP interactions | 5.55e-05 | 197 | 135 | 8 | int:PHIP | |
| Interaction | NR2C2 interactions | FLNA RC3H2 ILF3 IMPDH2 TCOF1 AIMP1 BAZ1B RRBP1 NDUFA10 SUCLG1 ADAR EMSY DDX1 HNRNPK HP1BP3 PARP1 UBAP2L FUBP1 DIAPH1 RPL22L1 MRPL24 HSPA5 THRAP3 | 5.57e-05 | 1403 | 135 | 23 | int:NR2C2 |
| Interaction | SSRP1 interactions | ILF3 HIRIP3 ATRX POLA1 CUL7 ADAR APLF HNRNPK PARP1 ZC3H11A BRCA2 MPHOSPH8 EIF3H HSPA5 THRAP3 | 5.65e-05 | 685 | 135 | 15 | int:SSRP1 |
| Interaction | CDK9 interactions | FLNA ILF3 HIRIP3 TCOF1 CKAP5 RRBP1 ADAR HNRNPK HP1BP3 CDC7 PARP1 BRCA2 PRRC2C FUBP1 HSPA5 | 5.65e-05 | 685 | 135 | 15 | int:CDK9 |
| Interaction | MEN1 interactions | ILF3 IMPDH2 ATRX TCOF1 POLA1 BAZ1B BTAF1 ADAR ASH2L EMSY DDX1 HP1BP3 ZC3H11A BRCA2 FUBP1 C4A SPEN MRPL24 THRAP3 | 5.67e-05 | 1029 | 135 | 19 | int:MEN1 |
| Interaction | RNF113A interactions | FLNA ILF3 TCOF1 AIMP1 SRP19 RRBP1 HNRNPK HP1BP3 FAM193A UBAP2L PRRC2C DIAPH1 HSPA5 THRAP3 SENP5 | 6.33e-05 | 692 | 135 | 15 | int:RNF113A |
| Interaction | SRRM2 interactions | FLNA NOG ILF3 BAZ1B CUL7 DDX1 HNRNPK SEPTIN2 PRRC2C EIF3H SPEN HSPA5 | 6.62e-05 | 462 | 135 | 12 | int:SRRM2 |
| Interaction | SOX2 interactions | SEMG2 FLNA ILF3 ARID4B IMPDH2 AIMP1 CKAP5 L1TD1 BAZ1B CUL7 ADAR ASH2L DDX1 HNRNPK SEPTIN2 PARP1 ZFHX4 FUBP1 C4A SPEN MRPL24 HSPA5 THRAP3 | 6.83e-05 | 1422 | 135 | 23 | int:SOX2 |
| Interaction | LGR4 interactions | 6.95e-05 | 262 | 135 | 9 | int:LGR4 | |
| Interaction | PABPC1 interactions | FOXO1 FLNA RC3H2 ILF3 AIMP1 SRP19 CUL7 DDX1 HNRNPK ZC3H11A SMG7 UBAP2L PRRC2C HSPA5 UVRAG | 7.09e-05 | 699 | 135 | 15 | int:PABPC1 |
| Interaction | SMURF1 interactions | FLNA TCOF1 PABPC1L2A SPART ASH2L HNRNPK HP1BP3 NEDD4 BMPR1B EIF3H HSPA5 UVRAG THRAP3 | 7.60e-05 | 544 | 135 | 13 | int:SMURF1 |
| Interaction | CGAS interactions | FOXO1 MIS18BP1 GBF1 BAZ1B RRBP1 HP1BP3 NEDD4 MPHOSPH8 RPL22L1 MRPL24 | 7.62e-05 | 329 | 135 | 10 | int:CGAS |
| Interaction | MAGEA9 interactions | 8.13e-05 | 208 | 135 | 8 | int:MAGEA9 | |
| Interaction | CEBPA interactions | FLNA AARS1 ILF3 IMPDH2 CKAP5 SRP19 ADAR EMSY DDX1 HNRNPK PRDM2 HP1BP3 SEPTIN2 TXNRD1 PARP1 ZC3H11A PRRC2C FUBP1 SPEN HSPA5 THRAP3 | 8.19e-05 | 1245 | 135 | 21 | int:CEBPA |
| Interaction | THOC1 interactions | 8.69e-05 | 210 | 135 | 8 | int:THOC1 | |
| Interaction | CPEB4 interactions | 8.80e-05 | 156 | 135 | 7 | int:CPEB4 | |
| Interaction | PRC1 interactions | FLNA AARS1 GBF1 ILF3 ATRX SYNE1 PABPC1L2A BAZ1B TACC2 NDUFA10 ZZEF1 ADAR DDX1 HNRNPK HP1BP3 CDC7 SPEN THRAP3 | 8.84e-05 | 973 | 135 | 18 | int:PRC1 |
| Interaction | DIAPH2 interactions | 9.30e-05 | 68 | 135 | 5 | int:DIAPH2 | |
| Interaction | SQSTM1 interactions | FOXO1 FLNA AARS1 GBF1 IMPDH2 SPART CUL7 RRBP1 NDUFA10 SUCLG1 ADAR NEDD4 ARFGAP2 PARP1 BMPR1B FAM193A SMG7 ALMS1 UBAP2L HSPA5 CNN2 | 9.38e-05 | 1257 | 135 | 21 | int:SQSTM1 |
| Interaction | WRN interactions | 9.79e-05 | 110 | 135 | 6 | int:WRN | |
| Interaction | ILF3 interactions | RC3H2 ILF3 CKAP5 CUL7 RRBP1 ADAR DDX1 HNRNPK HP1BP3 PARP1 PRRC2C DIAPH1 MPHOSPH8 RPL22L1 EIF3H SNCG HSPA5 | 1.04e-04 | 896 | 135 | 17 | int:ILF3 |
| Interaction | RPS16 interactions | RC3H2 NOG ILF3 CKAP5 SRP19 RRBP1 ADAR DDX1 HP1BP3 ADSS2 PRRC2C FUBP1 EIF3H USP1 HSPA5 | 1.05e-04 | 724 | 135 | 15 | int:RPS16 |
| Interaction | ARHGAP24 interactions | FLNA AARS1 ILF3 CMYA5 SUCLG1 ADAR DDX1 HNRNPK HP1BP3 PARP1 FUBP1 HSPA5 | 1.07e-04 | 486 | 135 | 12 | int:ARHGAP24 |
| Interaction | APEX1 interactions | ARID4B TCOF1 BAZ1B RAD9B ADAR EMSY HNRNPK PRDM2 HP1BP3 NEDD4 TXNRD1 METTL1 HAUS8 PARP1 FAM193A BRCA2 UNC5C LIMCH1 UVRAG THRAP3 CNN2 | 1.10e-04 | 1271 | 135 | 21 | int:APEX1 |
| Interaction | HSPA9 interactions | FOXO1 RC3H2 ILF3 ATRX AIMP1 CKAP5 SPART ODAD4 TACC2 CUL7 TXNRD1 PRRC2C EIF3H USP1 HSPA5 | 1.10e-04 | 727 | 135 | 15 | int:HSPA9 |
| Interaction | FBP1 interactions | 1.21e-04 | 348 | 135 | 10 | int:FBP1 | |
| Cytoband | 11q13.5 | 3.55e-05 | 21 | 140 | 3 | 11q13.5 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | FOXO1 FLNA MIS18BP1 ARID4B ATRX SYNE1 SPEF2 PHTF2 BAZ1B UNC13D BTAF1 RFX7 ADAR PRDM2 SEPTIN2 PARP1 ZC3H11A DIAPH1 MPHOSPH8 EIF3H SPEN NFAT5 FYB1 USP1 THRAP3 CNN2 | 3.95e-08 | 1492 | 135 | 26 | M40023 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | GBF1 ATRX CKAP5 BAZ1B SPART FNDC3A BTAF1 SOCS6 ZZEF1 NEDD4 TXNRD1 RAB3GAP1 FAM193A BRCA2 PRRC2C FUBP1 GLRB SPEN UVRAG | 8.85e-08 | 856 | 135 | 19 | M4500 |
| Coexpression | GRYDER_PAX3FOXO1_TOP_ENHANCERS | GBF1 BTAF1 ZZEF1 APLF DDX1 HNRNPK HP1BP3 TXNRD1 PARP1 BRCA2 LIMCH1 ADAMTS14 USP1 | 4.95e-07 | 441 | 135 | 13 | M172 |
| Coexpression | PUJANA_ATM_PCC_NETWORK | ILF3 TCOF1 POLA1 PHTF2 BAZ1B BTAF1 ADAR ADAM22 OPCML HNRNPK PRDM2 CD300C CDC7 PARP1 SMG7 UBAP2L PRRC2C FUBP1 DIAPH1 EIF3H USP1 UVRAG SENP5 | 7.02e-07 | 1394 | 135 | 23 | M9585 |
| Coexpression | GSE36826_NORMAL_VS_STAPH_AUREUS_INF_SKIN_UP | 9.19e-07 | 198 | 135 | 9 | M9534 | |
| Coexpression | IKEDA_MIR30_TARGETS_UP | 2.40e-06 | 116 | 135 | 7 | M2379 | |
| Coexpression | IKEDA_MIR30_TARGETS_UP | 2.55e-06 | 117 | 135 | 7 | MM931 | |
| Coexpression | FISCHER_DREAM_TARGETS | USP53 AARS1 MIS18BP1 ILF3 HIRIP3 TCOF1 POLA1 CKAP5 PHTF2 BAZ1B CDC7 HAUS8 ALMS1 BRCA2 RPL22L1 POLQ USP1 THRAP3 | 2.56e-06 | 969 | 135 | 18 | M149 |
| Coexpression | TABULA_MURIS_SENIS_SPLEEN_PROERYTHROBLAST_AGEING | IMPDH2 ACADL ATRX TCOF1 AIMP1 BAZ1B SRP19 RRBP1 NDUFA10 SUCLG1 HNRNPK HP1BP3 PRRC2C FUBP1 RPL22L1 USP1 MRPL24 HSPA5 THRAP3 | 6.65e-06 | 1144 | 135 | 19 | MM3843 |
| Coexpression | BENPORATH_CYCLING_GENES | USP53 MIS18BP1 POLA1 CKAP5 FABP1 HP1BP3 CDC7 TXNRD1 HAUS8 C4B POLQ USP1 THRAP3 CNN2 | 6.76e-06 | 648 | 135 | 14 | M8156 |
| Coexpression | SHEN_SMARCA2_TARGETS_UP | ARID4B ATRX SOCS6 SUCLG1 DENND4C DDX1 SEPTIN2 ADSS2 LIMCH1 USP1 UVRAG | 1.44e-05 | 429 | 135 | 11 | M29 |
| Coexpression | GRYDER_PAX3FOXO1_ENHANCERS_IN_TADS | FOXO1 NOG GBF1 BTAF1 ZZEF1 APLF DDX1 HNRNPK HP1BP3 CDC7 TXNRD1 PARP1 BRCA2 FUBP1 LIMCH1 ADAMTS14 USP1 | 1.77e-05 | 1009 | 135 | 17 | M157 |
| Coexpression | PUJANA_XPRSS_INT_NETWORK | 2.73e-05 | 168 | 135 | 7 | M18811 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | ATRX CKAP5 FNDC3A NEDD4 RAB3GAP1 PRRC2C FUBP1 GLRB LIMCH1 SPEN UVRAG | 3.09e-05 | 466 | 135 | 11 | M13522 |
| Coexpression | PUJANA_CHEK2_PCC_NETWORK | ILF3 AIMP1 POLA1 BAZ1B SRP19 CDC7 PARP1 SMG7 BRCA2 UBAP2L PRRC2C FUBP1 EIF3H USP1 | 4.00e-05 | 761 | 135 | 14 | M11961 |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | 4.24e-05 | 180 | 135 | 7 | M8239 | |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP | RC3H2 AARS1 MIS18BP1 HIRIP3 TCOF1 POLA1 CKAP5 CDC7 HAUS8 BRCA2 LIMCH1 USP1 | 4.66e-05 | 578 | 135 | 12 | M2368 |
| Coexpression | KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_DN | 5.22e-05 | 186 | 135 | 7 | M1993 | |
| Coexpression | ZHENG_GLIOBLASTOMA_PLASTICITY_UP | 5.81e-05 | 257 | 135 | 8 | MM1231 | |
| Coexpression | NGO_MALIGNANT_GLIOMA_1P_LOH | 5.81e-05 | 15 | 135 | 3 | M19965 | |
| Coexpression | CYCLIN_D1_UP.V1_DN | 5.97e-05 | 190 | 135 | 7 | M2652 | |
| Coexpression | GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN | 6.67e-05 | 338 | 135 | 9 | M17094 | |
| Coexpression | GSE45365_HEALTHY_VS_MCMV_INFECTION_CD11B_DC_IFNAR_KO_UP | 6.80e-05 | 194 | 135 | 7 | M9980 | |
| Coexpression | PUJANA_BRCA2_PCC_NETWORK | 7.49e-05 | 426 | 135 | 10 | M9516 | |
| Coexpression | GSE3982_MAC_VS_NKCELL_DN | 7.73e-05 | 198 | 135 | 7 | M5509 | |
| Coexpression | GSE360_HIGH_VS_LOW_DOSE_B_MALAYI_DC_DN | 8.23e-05 | 200 | 135 | 7 | M5225 | |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP | FLNA RC3H2 NOG ATRX AIMP1 DYNC2H1 CKAP5 BTAF1 TXNRD1 ST3GAL6 BRCA2 USP1 SENP5 | 9.35e-05 | 721 | 135 | 13 | M10237 |
| Coexpression | MENON_FETAL_KIDNEY_4_PODOCYTES | 9.90e-05 | 206 | 135 | 7 | M39254 | |
| Coexpression | DIAZ_CHRONIC_MYELOGENOUS_LEUKEMIA_UP | FLNA ILF3 ARID4B ATRX AIMP1 SRP19 SUCLG1 ASH2L DDX1 HNRNPK HP1BP3 CDC7 SEPTIN2 TXNRD1 ARFGAP2 PARP1 ADSS2 C4A USP1 | 1.04e-04 | 1399 | 135 | 19 | M535 |
| Coexpression | MENON_FETAL_KIDNEY_0_CAP_MESENCHYME_CELLS | 1.04e-04 | 90 | 135 | 5 | M39250 | |
| Coexpression | CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_1 | PCP4 FLNA AARS1 MIS18BP1 HIRIP3 IMPDH2 TCEAL4 PARP1 SYT1 RPL22L1 MRPL24 | 1.04e-04 | 534 | 135 | 11 | M12522 |
| Coexpression | SMITH_TERT_TARGETS_UP | 1.08e-04 | 145 | 135 | 6 | M17742 | |
| Coexpression | FOURNIER_ACINAR_DEVELOPMENT_LATE_2 | 1.08e-04 | 281 | 135 | 8 | M4077 | |
| Coexpression | HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP | 1.45e-04 | 153 | 135 | 6 | M5588 | |
| Coexpression | HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP | 1.56e-04 | 155 | 135 | 6 | MM1259 | |
| Coexpression | IKEDA_MIR1_TARGETS_UP | 1.74e-04 | 54 | 135 | 4 | MM927 | |
| Coexpression | IKEDA_MIR1_TARGETS_UP | 1.74e-04 | 54 | 135 | 4 | M2372 | |
| Coexpression | LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN | 2.11e-04 | 164 | 135 | 6 | M13108 | |
| Coexpression | KIM_BIPOLAR_DISORDER_OLIGODENDROCYTE_DENSITY_CORR_UP | CHL1 PCP4 AARS1 TCEAL4 SRP19 SUCLG1 ADAR DDX1 HNRNPK SEPTIN2 ARFGAP2 GLRB | 2.14e-04 | 680 | 135 | 12 | M2107 |
| Coexpression | ERWIN_COHEN_BLOOD_LIVE_VACCINE_TC_83_AGE_23_48YO_VACCINATED_VS_CONTROL_14DY_UP | USP53 ARID4B ANK3 AIMP1 PHTF2 SRP19 BTAF1 RFX7 DENND4C FUBP1 RPL22L1 USP1 | 2.35e-04 | 687 | 135 | 12 | M41022 |
| Coexpression | LAKE_ADULT_KIDNEY_C15_CONNECTING_TUBULE | 2.65e-04 | 171 | 135 | 6 | M39234 | |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP | RC3H2 MIS18BP1 HIRIP3 TCOF1 POLA1 CKAP5 CDC7 HAUS8 BRCA2 LIMCH1 USP1 | 2.74e-04 | 597 | 135 | 11 | MM1309 |
| Coexpression | LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_DN | CHL1 MTG1 GBF1 IMPDH2 DYNC2H1 BTAF1 EMSY PRDM2 HP1BP3 FAM193A SPEN UVRAG THRAP3 | 2.81e-04 | 807 | 135 | 13 | M14594 |
| Coexpression | YAGI_AML_WITH_INV_16_TRANSLOCATION | 2.89e-04 | 411 | 135 | 9 | M1047 | |
| Coexpression | GEORGES_CELL_CYCLE_MIR192_TARGETS | 2.98e-04 | 62 | 135 | 4 | M11038 | |
| Coexpression | ZHENG_GLIOBLASTOMA_PLASTICITY_UP | 3.17e-04 | 249 | 135 | 7 | M1796 | |
| Coexpression | DODD_NASOPHARYNGEAL_CARCINOMA_UP | ILF3 AIMP1 POLA1 CKAP5 BAZ1B ADAR FMNL2 ADAM22 CDC7 NEDD4 METTL1 ZC3H11A BRCA2 UBAP2L PRRC2C FUBP1 POLQ MRPL24 | 3.31e-04 | 1407 | 135 | 18 | M14427 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500_k-means-cluster#3 | 3.07e-06 | 192 | 131 | 9 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | POLA1 CKAP5 BTAF1 RFX7 SMG7 ALMS1 BRCA2 PRRC2C MPHOSPH8 POLQ USP1 HSPA5 THRAP3 NOVA1 | 5.42e-06 | 532 | 131 | 14 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | ARID4B HIRIP3 ATRX POLA1 CKAP5 BAZ1B FAM193A ALMS1 BRCA2 POLQ | 2.38e-05 | 311 | 131 | 10 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | MIS18BP1 GARNL3 ARID4B HIRIP3 ATRX TCOF1 MAP6 POLA1 CKAP5 BAZ1B RAD9B BTAF1 FMNL2 EMSY BMPR1B FAM193A ALMS1 BRCA2 FUBP1 GLRB MPHOSPH8 USP1 THRAP3 | 2.79e-05 | 1459 | 131 | 23 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | MIS18BP1 GARNL3 ARID4B HIRIP3 ATRX TCOF1 POLA1 CKAP5 BAZ1B RAD9B BTAF1 FMNL2 EMSY FAM193A ALMS1 BRCA2 FUBP1 GLRB MPHOSPH8 USP1 THRAP3 | 2.82e-05 | 1257 | 131 | 21 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | Fetal Liver, SC.STSL.FL, IgM- CD24- CD117+ IL7R- CD150- CD48- AA4.1+ CD43+, Fetal Liver, avg-2 | MIS18BP1 POLA1 PHTF2 CUL7 ARMCX4 FMNL2 CDC7 NEDD4 BRCA2 ARHGAP28 POLQ | 4.85e-05 | 410 | 131 | 11 | GSM791122_500 |
| CoexpressionAtlas | dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k-means-cluster#1_top-relative-expression-ranked_1000 | 5.06e-05 | 211 | 131 | 8 | gudmap_dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k1_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_500_k-means-cluster#5 | 9.83e-05 | 232 | 131 | 8 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_500_K5 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_1000 | USP53 RC3H2 MIS18BP1 ATRX L1TD1 FNDC3A SOCS6 TXNRD1 ZC3H11A ZFHX4 UBAP2L PRRC2C FUBP1 NFAT5 THRAP3 | 1.33e-04 | 804 | 131 | 15 | gudmap_developingGonad_e12.5_ovary_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#5 | ARID4B ATRX DYNC2H1 CKAP5 BAZ1B ZNF407 FNDC3A ADAM22 NEDD4 ZC3H11A BRCA2 UBAP2L GLRB | 1.42e-04 | 629 | 131 | 13 | Facebase_RNAseq_e10.5_Maxillary Arch_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | HIRIP3 ATRX DYNC2H1 POLA1 CKAP5 BAZ1B ARMCX4 NDUFA10 FMNL2 FAM193A ALMS1 BRCA2 MPHOSPH8 POLQ NOVA1 | 1.91e-04 | 831 | 131 | 15 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MandArch_2500_K1 | MIS18BP1 ARID4B ANK3 ATRX CKAP5 BAZ1B SRP19 TDRD1 EMSY CDC7 BMPR1B ALMS1 BRCA2 GLRB UNC5C RPL22L1 EIF3H USP1 THRAP3 | 2.20e-04 | 1241 | 131 | 19 | facebase_RNAseq_e10.5_MandArch_2500_K1 |
| CoexpressionAtlas | B cells, preB.FrC.BM, CD19+ IgM- CD45R+ CD43+ HSA+, Bone marrow, avg-3 | MIS18BP1 HIRIP3 IMPDH2 DYNC2H1 POLA1 CKAP5 CDC7 ALMS1 BRCA2 POLQ | 2.29e-04 | 409 | 131 | 10 | GSM399452_500 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MandArch_2500 | COL9A1 MIS18BP1 ARID4B ANK3 ATRX CKAP5 BAZ1B SRP19 UNC13D TDRD1 EMSY CDC7 BMPR1B ALMS1 BRCA2 GLRB UNC5C RPL22L1 EIF3H USP1 THRAP3 | 2.53e-04 | 1468 | 131 | 21 | facebase_RNAseq_e10.5_MandArch_2500 |
| CoexpressionAtlas | alpha beta T cells, T.ISP.Th, 4- 8+ TCR-/lo 24hi, Thymus, avg-3 | MIS18BP1 HIRIP3 IMPDH2 POLA1 CKAP5 CDC7 ALMS1 BRCA2 POLQ USP1 | 2.68e-04 | 417 | 131 | 10 | GSM399403_500 |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.18e-08 | 176 | 136 | 8 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-07 | 184 | 136 | 8 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.35e-07 | 191 | 136 | 8 | 60c986d2dcbc19d9338c03da6cb5e1d92fd48f8e | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.35e-07 | 191 | 136 | 8 | 973117730d6ba5f127e7a0bfabfd0ff2ca7ac131 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Neuronal-neurons_A-Branch_A2_(IPAN/IN)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.71e-07 | 197 | 136 | 8 | f7eaac1c321710a55e09ffb047a7db2baf7b7e28 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Neuronal-neurons_B-Branch_B2_(eMN)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.78e-07 | 198 | 136 | 8 | 85881637641d8996be2edc65c4bceff0433135e7 | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 1.92e-07 | 200 | 136 | 8 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| ToppCell | droplet-Marrow-nan-3m-Lymphocytic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.33e-06 | 179 | 136 | 7 | dcaf2191134a586d50ebaf67dcf5b815b54a722b | |
| ToppCell | droplet-Marrow-nan-3m-Lymphocytic-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.33e-06 | 179 | 136 | 7 | 87a69f9f83b8f0c028a4874acb238f2e079bf51f | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.66e-06 | 185 | 136 | 7 | 6712512100ccef456d2e2bd201d0987986c92ac9 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.91e-06 | 189 | 136 | 7 | 203c80030df08ae112f9ae4043709f455d87ce89 | |
| ToppCell | ILEUM-inflamed-(5)_Plasma-(5)_IgA_plasma_cells|(5)_Plasma / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.91e-06 | 189 | 136 | 7 | a0634d72bfdd5f93877724ed6480b50a3a046f71 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 1.91e-06 | 189 | 136 | 7 | a48df46274d51e84ffb40264646de7346104efb9 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 1.91e-06 | 189 | 136 | 7 | 0a82931b5f6c0a6427ca3edd5e2235ac49099d40 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|RV / Chamber and Cluster_Paper | 1.98e-06 | 190 | 136 | 7 | 93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.05e-06 | 191 | 136 | 7 | 09db184cb90fe282a14474d7217068c58092c6f8 | |
| ToppCell | RV-01._Fibroblast_I|RV / Chamber and Cluster_Paper | 2.12e-06 | 192 | 136 | 7 | 356160b113c3305a61ceeaff33ce3c9da0be2878 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.19e-06 | 193 | 136 | 7 | 516ea2c12bdc7a5dc676159d627e36f6abe13ef0 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.27e-06 | 194 | 136 | 7 | 8ef0b71fef5b84cfd04973f891215333e7035d1d | |
| ToppCell | IPF-Multiplet-Multiplet|IPF / Disease state, Lineage and Cell class | 2.35e-06 | 195 | 136 | 7 | fce0c29574bb7aab181b9c00feb42681e285d1f2 | |
| ToppCell | IPF-Multiplet|IPF / Disease state, Lineage and Cell class | 2.35e-06 | 195 | 136 | 7 | eacc0449ae6f3ad8002268cd061467684c6fb9a7 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.35e-06 | 195 | 136 | 7 | 5c86fddd6d0530beecf45ea5ba6b823123847696 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(3)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.43e-06 | 196 | 136 | 7 | df366d76ea55f49e349d622effa57c1535df8400 | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.43e-06 | 196 | 136 | 7 | 0644bd14a944b9c9759a295dfdd5e67a4775f20a | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.43e-06 | 196 | 136 | 7 | 151f1a29a91f8b234e9b6ed062666357a2f69128 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal-neurons_A-Branch_A2_(IPAN/IN)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.51e-06 | 197 | 136 | 7 | 27c044833e471a312a572e0b1c83e4bc8a36e896 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal-neurons_A-Branch_A1_(iMN)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.51e-06 | 197 | 136 | 7 | fd43fc1cbf0c17b370397d73dddc572565a759c7 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal-neurons_A|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.60e-06 | 198 | 136 | 7 | 800ade4261695f2efd869d2b1243571de963c431 | |
| ToppCell | (00)_Basal-(2)_GFP_FOXI1|(00)_Basal / shred by cell type by condition | 2.69e-06 | 199 | 136 | 7 | 19674e1eaeb51e4196d847cb62aa437c852951d3 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Neuronal-neurons_A|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.69e-06 | 199 | 136 | 7 | ce8dbfd969b3b9c08e1c57c2bfd899818e878731 | |
| ToppCell | megakaryocytic-CD34+_Megakaryoblast|megakaryocytic / Lineage and Cell class | 2.69e-06 | 199 | 136 | 7 | 99a65887d3c8a2cde26693dd74404b101bba9d58 | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.78e-06 | 200 | 136 | 7 | 87827041663013f5e7273168dc8709d69840e7ce | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.78e-06 | 200 | 136 | 7 | 09537dc25f8b8b4654a7c183827ee1522a41a4e0 | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.78e-06 | 200 | 136 | 7 | 8988f113708eef7d9d2a6a6c1bcfd7c8f9804d3e | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.78e-06 | 200 | 136 | 7 | 08bf8c00eee6468215edb3611296bfc8784c4d56 | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Myofibroblastic|LPS_only / Treatment groups by lineage, cell group, cell type | 2.78e-06 | 200 | 136 | 7 | 02cae2c296a13ad4cbb53bca7a86d64629d67d66 | |
| ToppCell | TCGA-Peripheral_Nervous_System-Primary_Tumor-Paraganglioma-Paraganglioma-3|TCGA-Peripheral_Nervous_System / Sample_Type by Project: Shred V9 | 3.73e-06 | 135 | 136 | 6 | ac20133d4a36f48338b45bffb13e842cb66f83ad | |
| ToppCell | E16.5-samps|World / Age Group, Lineage, Cell class and subclass | 6.58e-06 | 149 | 136 | 6 | e94d075f68c1c70c89fab50b1b765b5dda650d09 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.87e-06 | 157 | 136 | 6 | 2c5295043611bac7dfa4aef2146681bce4a33a8f | |
| ToppCell | Ciliated_cells-A-HP_01|World / lung cells shred on cell class, cell subclass, sample id | 9.53e-06 | 159 | 136 | 6 | 0c65ae6140abd48c79b04758a6217709ddd15385 | |
| ToppCell | Control|World / group, cell type (main and fine annotations) | 1.30e-05 | 168 | 136 | 6 | a3511faf2cd2c2b9c8363c8b99da3f3609c43ed6 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.30e-05 | 168 | 136 | 6 | fc80e4fecfc92458eb627013a983041d8ca025a9 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.30e-05 | 168 | 136 | 6 | e96859dbf51cf8c4def8ee8db132f4d874fb4381 | |
| ToppCell | PND07-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2-CAP2_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.35e-05 | 169 | 136 | 6 | 8a6d05b5d60b2b2e43a8ff7521feb79cd6dbd940 | |
| ToppCell | (0)_Normal/No_Treatment-(3)_LEPR+_perivascular_cells|World / Stress and Cell class | 1.70e-05 | 176 | 136 | 6 | ce2c32b5ce0da848eb4da35ce4d215cdf74d9113 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.81e-05 | 178 | 136 | 6 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Mesenchymal-ependymal_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.81e-05 | 178 | 136 | 6 | b1db59344c074c7c80169fc2c5cd5fc89f3fe463 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Mesenchymal-Ependyma|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.81e-05 | 178 | 136 | 6 | 579cdc14f28b459e200ae2102e0bd4df8a2c0dcb | |
| ToppCell | RA-16._Neuronal|World / Chamber and Cluster_Paper | 1.99e-05 | 181 | 136 | 6 | 7d22a43f887e0747f0cb87ba364ff27905ee6eec | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|LV / Chamber and Cluster_Paper | 2.18e-05 | 184 | 136 | 6 | ab7a1620c14a9d9b6be1b47c559931e345e9eef8 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.25e-05 | 185 | 136 | 6 | 7adfa929930cfa795cbfbd9f1a0b439e08aa765d | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 2.25e-05 | 185 | 136 | 6 | 6baccb26f999145e51b91d94315bf8d4655bef31 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 2.46e-05 | 188 | 136 | 6 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | droplet-Tongue-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.46e-05 | 188 | 136 | 6 | d62cc37e86b7b186e53aeb7f421c4e5ee28f23bd | |
| ToppCell | Epithelial-Epithelial-D_(Ciliated)|Epithelial / shred on cell class and cell subclass (v4) | 2.46e-05 | 188 | 136 | 6 | 8f30535a32968a81a304315a49c0d90a77d36948 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM2_(12)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.46e-05 | 188 | 136 | 6 | 3004e961d214919e08c7cd5f10c3de5cf85b35a3 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_myocytic|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.54e-05 | 189 | 136 | 6 | f75cebd4c3e54e297557449ba67ccc8d1a2a14f5 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-intestinal_crypt_stem_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.61e-05 | 190 | 136 | 6 | 52c59001a079c76249abbaa3141e9e661b83d9a0 | |
| ToppCell | LV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 2.61e-05 | 190 | 136 | 6 | 12992ec80a7b4f4f17de693f0719ee061a9918fd | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_B-B_cell-B_c03-CD27-AIM2|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.61e-05 | 190 | 136 | 6 | 0db545a4cba7534bad2693e0d565cde7dbc7a586 | |
| ToppCell | pdx-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 2.61e-05 | 190 | 136 | 6 | d06ee5f89f1cec8db6897fe3b2a890a07cd3697b | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Inner_Medullary_Collecting_Duct_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.69e-05 | 191 | 136 | 6 | 3e828cffa24ded19f591a7ed6c1fe88ad57fdcac | |
| ToppCell | RV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 2.69e-05 | 191 | 136 | 6 | 70c067c54084bfb02c29bab085f4defd477194fb | |
| ToppCell | droplet-Tongue-TONGUE-1m-Epithelial-suprabasal_differentiating|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.85e-05 | 193 | 136 | 6 | 49f4fbec91acda4727703e0e359ed780eefb8a22 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.85e-05 | 193 | 136 | 6 | b3ad5ff480d99217f36cc7471e5a96a519ddb409 | |
| ToppCell | RV-02._Fibroblast_II|RV / Chamber and Cluster_Paper | 2.94e-05 | 194 | 136 | 6 | 11c79a8c56ece42713b04b321982e41e239f07a5 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.94e-05 | 194 | 136 | 6 | e93de9428c986b8943fc169258847c650cfab0e5 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.94e-05 | 194 | 136 | 6 | e3d63874111d1e8da3977329426e4dcf68d6de87 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(3)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.02e-05 | 195 | 136 | 6 | cec7df321f372d05c94f97d6bb18891a5cc3dec3 | |
| ToppCell | COVID-19_Severe-B_memory|COVID-19_Severe / disease group, cell group and cell class | 3.02e-05 | 195 | 136 | 6 | 54becd9e283639638fc5f13eddce224aed9391da | |
| ToppCell | IPF-Multiplet-Multiplet|World / Disease state, Lineage and Cell class | 3.02e-05 | 195 | 136 | 6 | 21dbdc803c6947024dc2416e9e21c2ef0af9bc31 | |
| ToppCell | RV-02._Fibroblast_II|World / Chamber and Cluster_Paper | 3.02e-05 | 195 | 136 | 6 | ce90b30dcdb56d4cd925cdb79fd9d7cefd998f48 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Neuronal-neurons_A-Branch_A3_(IPAN/IN)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.02e-05 | 195 | 136 | 6 | 5a6a5048af638872700b76b7c71a8fa3fb8d3772 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.11e-05 | 196 | 136 | 6 | 66d76249bd2770cdddff2c1fe59a016e95da2124 | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.11e-05 | 196 | 136 | 6 | 20383d576708b7e4bfce3e9fe40548cce496e3cb | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.11e-05 | 196 | 136 | 6 | f374cb3ec31c6eef2cef9e07547bfd1e380553af | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.11e-05 | 196 | 136 | 6 | 671c380b58d7f634b4fbec38c357d357ea4f3535 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.11e-05 | 196 | 136 | 6 | 9bd4c146fc7555e32adfa393b3a07846eb826d25 | |
| ToppCell | IPF-Epithelial|IPF / Disease state, Lineage and Cell class | 3.11e-05 | 196 | 136 | 6 | 87d9881cfec461a5d89b688a83749b618c519485 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal-skeletal_muscle_satellite_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.20e-05 | 197 | 136 | 6 | 5bc11aff92da2a0aca8473f997fe7a99f3cae75d | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Neuronal-neurons_B-Branch_B2_(eMN)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.20e-05 | 197 | 136 | 6 | b9478212f14b7888e3abac02995177974ac3bd17 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.20e-05 | 197 | 136 | 6 | 91637bdeab85024b5a02d1066f76cb803a2d6420 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.20e-05 | 197 | 136 | 6 | 22c87dd15dc57bd0aa98a204c9fc9b3b9b573b45 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.20e-05 | 197 | 136 | 6 | 3bbf068d2ad8196fbc85d3f311a7c54c9aece856 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.20e-05 | 197 | 136 | 6 | 87db09f341e2b20eb6e1c3e917cb5c960387b3e9 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Neuronal-neurons_A-Branch_A1_(iMN)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.29e-05 | 198 | 136 | 6 | 328f1d5d8168e05edd301d3a0f2eb5c6cd1c67c8 | |
| ToppCell | Control-CD4+_T|Control / Disease group and Cell class | 3.29e-05 | 198 | 136 | 6 | 2682eea9b34cfc7e82891c1f1117d3c874107af6 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.29e-05 | 198 | 136 | 6 | 02d0d8a212e09c0962ab1dae6a885d26d357f66a | |
| ToppCell | mild-B_memory|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.39e-05 | 199 | 136 | 6 | e6ac9a0959b0de2c6a99298feb7715aa80ade1dd | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.39e-05 | 199 | 136 | 6 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | (04)_Interm._basal>secr.-(2)_GFP_FOXI1|(04)_Interm._basal>secr. / shred by cell type by condition | 3.39e-05 | 199 | 136 | 6 | 53ca3861f9e00dab3f3fbefb0837857ee39ab084 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.39e-05 | 199 | 136 | 6 | 38cfd367ee8c074c11ba54edeb7a001e375e2687 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.39e-05 | 199 | 136 | 6 | 19a97e27a4758e794ce7246d295e112b47931a48 | |
| ToppCell | Neuron|World / Primary Cells by Cluster | 3.39e-05 | 199 | 136 | 6 | 1f8104fd92f04690b41d9d07ac08dc59d76bb97d | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.39e-05 | 199 | 136 | 6 | 6b3a0e5d52a30d0eed30e6a670f5b53bc233f70c | |
| ToppCell | Neuron-Postmitotic|World / Primary Cells by Cluster | 3.39e-05 | 199 | 136 | 6 | 1973527f8a7d4c6490d75c0d0ea153688166a08b | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-Mono-Mono_hypoxia-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.39e-05 | 199 | 136 | 6 | 379bbd9cecf466b902411c54d74bd9885285b1ba | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_|World / Primary Cells by Cluster | 3.39e-05 | 199 | 136 | 6 | 058373b4ac3cec2108cb24265628ff0a50646e33 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-FOXM1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.48e-05 | 200 | 136 | 6 | 4cfe08878a6981bf7b3567f9e82192d8f060ddde | |
| ToppCell | Bronchial_Brush-Epithelial-Basal_2|Bronchial_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 3.48e-05 | 200 | 136 | 6 | 1fa29a9f42987549a75dffeb177099458f7cca88 | |
| Computational | Genes in the cancer module 32. | 1.95e-04 | 241 | 91 | 9 | MODULE_32 | |
| Computational | Nucleotide metabolism. | 2.00e-04 | 64 | 91 | 5 | MODULE_337 | |
| Drug | bromfenacoum | PCP4 AARS1 ANK3 ATRX AIMP1 MAP6 RRBP1 NDUFA10 HNRNPK HP1BP3 TXNRD1 ARFGAP2 UBAP2L SYT1 LIMCH1 PICK1 | 1.29e-06 | 644 | 134 | 16 | ctd:C013418 |
| Drug | Sulfaphenazole [526-08-9]; Down 200; 12.8uM; MCF7; HT_HG-U133A | 1.42e-05 | 185 | 134 | 8 | 1673_DN | |
| Drug | Neostigmine bromide [114-80-7]; Down 200; 13.2uM; PC3; HT_HG-U133A | 1.60e-05 | 188 | 134 | 8 | 6735_DN | |
| Drug | Sulfamethazine sodium salt [1981-58-4]; Down 200; 13.4uM; PC3; HT_HG-U133A | 1.73e-05 | 190 | 134 | 8 | 4322_DN | |
| Drug | Flunisolide [3385-03-3]; Down 200; 9.2uM; PC3; HT_HG-U133A | 1.79e-05 | 191 | 134 | 8 | 4303_DN | |
| Drug | Talampicillin hydrochloride [39878-70-1]; Up 200; 7.8uM; PC3; HT_HG-U133A | 2.08e-05 | 195 | 134 | 8 | 7254_UP | |
| Drug | Riluzole hydrochloride; Down 200; 14.8uM; MCF7; HT_HG-U133A | 2.16e-05 | 196 | 134 | 8 | 4689_DN | |
| Drug | CGX 0596987; Down 200; 20uM; PC3; HT_HG-U133A | 2.24e-05 | 197 | 134 | 8 | 6369_DN | |
| Drug | oxarbazole | 3.44e-05 | 2 | 134 | 2 | CID000037184 | |
| Drug | methoxyfenozide | 4.22e-05 | 12 | 134 | 3 | CID000105010 | |
| Drug | ppGp | 5.46e-05 | 13 | 134 | 3 | CID000188347 | |
| Drug | geldanamycin | MIS18BP1 ATRX PHTF2 RFX7 PARP1 ZC3H11A ZFHX4 PRRC2C NFAT5 HSPA5 | 7.12e-05 | 371 | 134 | 10 | ctd:C001277 |
| Drug | 2',3'-dideoxyguanosine | 8.89e-05 | 40 | 134 | 4 | CID000064974 | |
| Drug | Etifenin [63245-28-3]; Down 200; 12.4uM; PC3; HT_HG-U133A | 9.04e-05 | 178 | 134 | 7 | 3998_DN | |
| Drug | 2-deoxyguanosine | 9.04e-05 | 178 | 134 | 7 | CID000000638 | |
| Drug | Captopril [62571-86-2]; Down 200; 17.2uM; PC3; HT_HG-U133A | 9.36e-05 | 179 | 134 | 7 | 4585_DN | |
| Drug | 2-aminothiophenol | 1.03e-04 | 3 | 134 | 2 | ctd:C005464 | |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 1.04e-04 | 182 | 134 | 7 | 3887_DN | |
| Drug | pioglitazone HCl; Down 200; 10uM; PC3; HT_HG-U133A | 1.07e-04 | 183 | 134 | 7 | 7088_DN | |
| Drug | Primaquine diphosphate [63-45-6]; Down 200; 8.8uM; MCF7; HT_HG-U133A | 1.19e-04 | 186 | 134 | 7 | 3279_DN | |
| Drug | carmustine; Up 200; 100uM; PC3; HT_HG-U133A | 1.23e-04 | 187 | 134 | 7 | 6883_UP | |
| Drug | Chlorambucil [305-03-3]; Down 200; 13.2uM; PC3; HT_HG-U133A | 1.31e-04 | 189 | 134 | 7 | 3788_DN | |
| Drug | Resveratrol [501-36-0]; Down 200; 17.6uM; PC3; HT_HG-U133A | 1.31e-04 | 189 | 134 | 7 | 5084_DN | |
| Drug | Ampyrone [83-07-8]; Down 200; 19.6uM; PC3; HT_HG-U133A | 1.36e-04 | 190 | 134 | 7 | 4507_DN | |
| Drug | Sulconazole nitrate [61318-91-0]; Down 200; 8.6uM; MCF7; HT_HG-U133A | 1.36e-04 | 190 | 134 | 7 | 3373_DN | |
| Drug | Phenformin hydrochloride [834-28-6]; Down 200; 16.6uM; PC3; HT_HG-U133A | 1.40e-04 | 191 | 134 | 7 | 4283_DN | |
| Drug | Clomipramine hydrochloride [17321-77-6]; Up 200; 11.4uM; PC3; HT_HG-U133A | 1.40e-04 | 191 | 134 | 7 | 4487_UP | |
| Drug | Meclofenoxate hydrochloride [3685-84-5]; Down 200; 13.6uM; PC3; HT_HG-U133A | 1.45e-04 | 192 | 134 | 7 | 4268_DN | |
| Drug | Pronethalol hydrochloride [51-02-5]; Down 200; 15uM; MCF7; HT_HG-U133A | 1.45e-04 | 192 | 134 | 7 | 4104_DN | |
| Drug | Cyanocobalamin [68-19-9]; Down 200; 3uM; MCF7; HT_HG-U133A | 1.45e-04 | 192 | 134 | 7 | 3252_DN | |
| Drug | NSC351140 | 1.49e-04 | 258 | 134 | 8 | CID000002210 | |
| Drug | Zaprinast [37762-06-4]; Down 200; 14.8uM; PC3; HT_HG-U133A | 1.49e-04 | 193 | 134 | 7 | 6749_DN | |
| Drug | Melatonin [73-31-4]; Down 200; 17.2uM; MCF7; HT_HG-U133A | 1.49e-04 | 193 | 134 | 7 | 3293_DN | |
| Drug | Ethoxyquin [91-53-2]; Down 200; 18.4uM; PC3; HT_HG-U133A | 1.49e-04 | 193 | 134 | 7 | 4321_DN | |
| Drug | Betahistine mesylate [54856-23-4]; Down 200; 17.2uM; MCF7; HT_HG-U133A | 1.49e-04 | 193 | 134 | 7 | 2833_DN | |
| Drug | Etofylline [519-37-9]; Up 200; 17.8uM; PC3; HT_HG-U133A | 1.49e-04 | 193 | 134 | 7 | 2093_UP | |
| Drug | Omeprazole [73590-58-6]; Down 200; 11.6uM; MCF7; HT_HG-U133A | 1.49e-04 | 193 | 134 | 7 | 2828_DN | |
| Drug | Dehydroisoandosterone 3-acetate [853-23-6]; Up 200; 12.2uM; PC3; HT_HG-U133A | 1.54e-04 | 194 | 134 | 7 | 6673_UP | |
| Drug | Piperacillin sodium salt [59703-84-3]; Down 200; 7.4uM; PC3; HT_HG-U133A | 1.54e-04 | 194 | 134 | 7 | 4320_DN | |
| Drug | Flutamide [13311-84-7]; Down 200; 14.4uM; MCF7; HT_HG-U133A | 1.54e-04 | 194 | 134 | 7 | 4361_DN | |
| Drug | Benfotiamine [22457-89-2]; Down 200; 8.6uM; PC3; HT_HG-U133A | 1.54e-04 | 194 | 134 | 7 | 4312_DN | |
| Drug | Prednisone [53-03-2]; Up 200; 11.2uM; PC3; HT_HG-U133A | 1.59e-04 | 195 | 134 | 7 | 4577_UP | |
| Drug | Methazolamide [554-57-4]; Up 200; 17uM; HL60; HT_HG-U133A | 1.59e-04 | 195 | 134 | 7 | 2733_UP | |
| Drug | Cefepime hydrochloride [123171-59-5]; Down 200; 7.4uM; HL60; HT_HG-U133A | 1.59e-04 | 195 | 134 | 7 | 6159_DN | |
| Drug | (+,-)-Synephrine [94-07-5]; Down 200; 24uM; MCF7; HT_HG-U133A | 1.64e-04 | 196 | 134 | 7 | 6798_DN | |
| Drug | Mefenamic acid [61-68-7]; Down 200; 16.6uM; PC3; HT_HG-U133A | 1.64e-04 | 196 | 134 | 7 | 1821_DN | |
| Drug | Sulfamethazine sodium salt [1981-58-4]; Up 200; 13.4uM; HL60; HT_HG-U133A | 1.64e-04 | 196 | 134 | 7 | 2560_UP | |
| Drug | Isoconazole [27523-40-6]; Up 200; 9.6uM; PC3; HT_HG-U133A | 1.64e-04 | 196 | 134 | 7 | 2056_UP | |
| Drug | Piromidic acid [19562-30-2]; Down 200; 13.8uM; PC3; HT_HG-U133A | 1.70e-04 | 197 | 134 | 7 | 4575_DN | |
| Drug | Iopanoic acid [96-83-3]; Up 200; 7uM; MCF7; HT_HG-U133A | 1.75e-04 | 198 | 134 | 7 | 3527_UP | |
| Drug | Glafenine hydrochloride [65513-72-6]; Up 200; 9.8uM; PC3; HT_HG-U133A | 1.75e-04 | 198 | 134 | 7 | 7257_UP | |
| Drug | Dienestrol [84-17-3]; Down 200; 15uM; MCF7; HT_HG-U133A | 1.75e-04 | 198 | 134 | 7 | 6208_DN | |
| Drug | Oxybutynin chloride [1508-65-2]; Up 200; 10.2uM; PC3; HT_HG-U133A | 1.75e-04 | 198 | 134 | 7 | 7126_UP | |
| Drug | Ketotifen fumarate [34580-14-8]; Down 200; 9.4uM; MCF7; HT_HG-U133A | 1.75e-04 | 198 | 134 | 7 | 7199_DN | |
| Drug | isomenthone | 1.80e-04 | 19 | 134 | 3 | CID000006986 | |
| Drug | AC1L1EVQ | 1.80e-04 | 19 | 134 | 3 | CID000002970 | |
| Drug | Retrorsine [480-54-6]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 1.81e-04 | 199 | 134 | 7 | 4946_DN | |
| Drug | Cefixime [79350-37-1]; Down 200; 8.8uM; MCF7; HT_HG-U133A | 1.81e-04 | 199 | 134 | 7 | 4390_DN | |
| Drug | Pyrilamine maleate [59-33-6]; Down 200; 10uM; HL60; HG-U133A | 1.81e-04 | 199 | 134 | 7 | 1568_DN | |
| Drug | haloperidol; Down 200; 10uM; MCF7; HT_HG-U133A | 1.81e-04 | 199 | 134 | 7 | 6963_DN | |
| Drug | Alprenolol hydrochloride [13707-88-5]; Down 200; 14uM; MCF7; HT_HG-U133A | 1.86e-04 | 200 | 134 | 7 | 6789_DN | |
| Drug | S(-)Eticlopride hydrochloride [97612-24-3]; Up 200; 10.6uM; HL60; HT_HG-U133A | 1.86e-04 | 200 | 134 | 7 | 3056_UP | |
| Drug | Minoxidil [38304-91-5]; Up 200; 19.2uM; PC3; HG-U133A | 1.86e-04 | 200 | 134 | 7 | 1914_UP | |
| Drug | Cefotetan [69712-56-7]; Down 200; 7uM; PC3; HT_HG-U133A | 1.86e-04 | 200 | 134 | 7 | 3997_DN | |
| Disease | Disproportionate short stature | 2.53e-05 | 77 | 132 | 5 | C0878659 | |
| Disease | Malignant neoplasm of breast | AKAP6 FLNA DYNC2H1 SYNE1 TACC2 ADAR EMSY HNRNPK NEDD4 PARP1 ZC3H11A BRCA2 OTOF ANKEF1 SNCG SPEN | 2.56e-05 | 1074 | 132 | 16 | C0006142 |
| Disease | osteochondrodysplasia (is_implicated_in) | 8.05e-05 | 19 | 132 | 3 | DOID:2256 (is_implicated_in) | |
| Disease | Mammary Carcinoma, Human | FLNA DYNC2H1 SYNE1 ADAR EMSY HNRNPK PARP1 ZC3H11A BRCA2 SNCG | 1.31e-04 | 525 | 132 | 10 | C4704874 |
| Disease | Mammary Neoplasms, Human | FLNA DYNC2H1 SYNE1 ADAR EMSY HNRNPK PARP1 ZC3H11A BRCA2 SNCG | 1.31e-04 | 525 | 132 | 10 | C1257931 |
| Disease | Mammary Neoplasms | FLNA DYNC2H1 SYNE1 ADAR EMSY HNRNPK PARP1 ZC3H11A BRCA2 SNCG | 1.35e-04 | 527 | 132 | 10 | C1458155 |
| Disease | Breast Carcinoma | FLNA DYNC2H1 SYNE1 ADAR EMSY HNRNPK PARP1 ZC3H11A BRCA2 SNCG | 1.60e-04 | 538 | 132 | 10 | C0678222 |
| Disease | uromodulin measurement | 2.11e-04 | 26 | 132 | 3 | EFO_0021778 | |
| Disease | selenium measurement | 2.94e-04 | 29 | 132 | 3 | EFO_0006331 | |
| Disease | energy intake | 3.49e-04 | 134 | 132 | 5 | EFO_0003939 | |
| Disease | nasal disorder | 5.16e-04 | 35 | 132 | 3 | MONDO_0002436 | |
| Disease | triacylglycerol 56:2 measurement | 1.06e-03 | 11 | 132 | 2 | EFO_0010429 | |
| Disease | craniosynostosis (is_implicated_in) | 1.27e-03 | 12 | 132 | 2 | DOID:2340 (is_implicated_in) | |
| Disease | Fetal Alcohol Spectrum Disorders | 1.50e-03 | 13 | 132 | 2 | C2985290 | |
| Disease | creatinine measurement, glomerular filtration rate | 1.92e-03 | 117 | 132 | 4 | EFO_0004518, EFO_0005208 | |
| Disease | Schizophrenia | CHL1 CACNA1F ANK3 MAP6 FOLH1 CMYA5 OPCML ADSS2 UNC5C DKK4 PICK1 | 2.10e-03 | 883 | 132 | 11 | C0036341 |
| Disease | Spondyloepiphyseal Dysplasia | 2.29e-03 | 16 | 132 | 2 | C0038015 | |
| Disease | Spondyloepiphyseal Dysplasia Tarda, X-Linked | 2.29e-03 | 16 | 132 | 2 | C3541456 | |
| Disease | Schwartz-Jampel Syndrome, Type 1 | 2.29e-03 | 16 | 132 | 2 | C4551479 | |
| Disease | Schwartz-Jampel Syndrome | 2.29e-03 | 16 | 132 | 2 | C0036391 | |
| Disease | Melnick-Needles Syndrome | 2.29e-03 | 16 | 132 | 2 | C0025237 | |
| Disease | Van Buchem disease | 2.58e-03 | 17 | 132 | 2 | C0432272 | |
| Disease | Fetal Alcohol Syndrome | 2.58e-03 | 17 | 132 | 2 | C0015923 | |
| Disease | response to mitochondrial complex I inhibitor | 3.23e-03 | 19 | 132 | 2 | EFO_0600033 | |
| Disease | Osteochondrodysplasias | 3.23e-03 | 19 | 132 | 2 | C0029422 | |
| Disease | Dyschondroplasias | 3.23e-03 | 19 | 132 | 2 | C0013366 | |
| Disease | Multiple Epiphyseal Dysplasia | 3.58e-03 | 20 | 132 | 2 | C0026760 | |
| Disease | sporadic amyotrophic lateral sclerosis | 3.67e-03 | 140 | 132 | 4 | EFO_0001357 | |
| Disease | Prostate cancer, familial | 3.70e-03 | 69 | 132 | 3 | C2931456 | |
| Disease | Nonorganic psychosis | 3.70e-03 | 69 | 132 | 3 | C0349204 | |
| Disease | Intellectual Disability | 4.07e-03 | 447 | 132 | 7 | C3714756 | |
| Disease | eosinophil percentage of granulocytes | 4.11e-03 | 234 | 132 | 5 | EFO_0007996 | |
| Disease | Hereditary hearing loss and deafness | 4.26e-03 | 146 | 132 | 4 | cv:C0236038 | |
| Disease | Colorectal Carcinoma | 4.41e-03 | 702 | 132 | 9 | C0009402 | |
| Disease | insomnia, total blood protein measurement | 4.47e-03 | 148 | 132 | 4 | EFO_0004536, EFO_0004698 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GINGEVVGSKGDRKK | 91 | Q9BXT4 | |
| KACTGQKRVKDAQGG | 1111 | Q4LE39 | |
| SKGGLGKEESQNEKQ | 261 | Q8IYS0 | |
| KGGNVGKSKRDQIVT | 681 | Q9UKH3 | |
| KGKGGSGDSAVKQVQ | 26 | O15372 | |
| IQGSGKEEICKDKSQ | 211 | Q8IW19 | |
| SLGSKINVKVGGNSK | 1361 | P0C0L5 | |
| INVKVGGNSKGTLKV | 1366 | P0C0L5 | |
| GAGSDLQGIKTNAKK | 176 | P28330 | |
| KENGKVENGLGKTDR | 806 | Q9UIG0 | |
| GEKKEKKQQSIAGSA | 131 | Q12904 | |
| KAGDTSKGGIAKVTQ | 476 | Q8TCU4 | |
| EKLNIEGTEKGNCGK | 571 | Q9P0K1 | |
| GVPTTSEGKKVQKGN | 686 | Q9NU02 | |
| RNITKEVGKGNEGKE | 386 | Q9NZW4 | |
| GAKKGLGAQKVSSQS | 226 | Q8N6H7 | |
| AQTKTSKAKKDQEGG | 821 | O60610 | |
| AGKLNVGTKKEDGES | 6 | O00238 | |
| KKKGDRVNNSIDGVS | 1156 | P78312 | |
| FQGEALLGTKNKVKG | 636 | Q5H9R4 | |
| VKGTLGKASKQAGAL | 716 | Q8WXS8 | |
| KQQDGGTTGTTKKAR | 301 | Q9UBL3 | |
| DKIVETKGSAGKRNG | 66 | Q08708 | |
| IKQVKGKGASGSFVV | 216 | Q5SSJ5 | |
| VKKVGKVGANGQNAA | 521 | Q9HBD1 | |
| DTEELKGNGQESGKK | 591 | Q15042 | |
| KKTAEAGGVTGKGQD | 86 | P09874 | |
| GKGQDGIGSKAEKTL | 96 | P09874 | |
| DLIEKKAGKNVTGQA | 296 | Q6WBX8 | |
| KSGVGNVFIKNLGKT | 86 | Q5JQF8 | |
| EEGNSQPKGTKGQNK | 1731 | O60840 | |
| VEGNKGTKSLKESEQ | 211 | Q9BW71 | |
| EGTSQQKVKEGNGKT | 311 | Q6P0N0 | |
| QKVKEGNGKTVPGET | 316 | Q6P0N0 | |
| QAVSGQAAKKKSAEG | 401 | Q96JE9 | |
| NGGSEIVVTNKNKKE | 1136 | P46934 | |
| SKGIGKISGVNLTQK | 1016 | O00533 | |
| KAGLVIGKGGETIKQ | 196 | Q96AE4 | |
| KIKVAQGVSGAVQDK | 436 | P12268 | |
| GNKVKNAQLAGAKGV | 211 | Q04609 | |
| QQEGKKGKTTIKTGA | 71 | Q92499 | |
| LGKTQKVKVLTGTGN | 276 | Q9BT17 | |
| NGKDKTSGENDGQKK | 11 | P48539 | |
| TEKKIQVGLGASGKE | 1336 | Q14999 | |
| DVKGGKNELSFKQGE | 521 | O15117 | |
| KKEEKLGSGQSPTQG | 386 | Q8N4P6 | |
| EQADGKGGNVAKKNT | 371 | P48167 | |
| KGGNVAKKNTVNGTG | 376 | P48167 | |
| LLQKSKADSSGVGKG | 71 | Q9BT25 | |
| GNGTLENQKGTGVKK | 251 | O94916 | |
| INSQGGRKVKAGDTV | 1161 | P09884 | |
| TVDGNICTGKGKLAK | 61 | O95299 | |
| ISKAKNTGVSVGQKG | 226 | Q14982 | |
| FEQIIKNSKAGSGGK | 646 | Q8NCM8 | |
| AGNTGTKNKKGLETK | 566 | Q14008 | |
| GIKQIKNGTTDGEKK | 1031 | P46100 | |
| AKKKASLQSGQEGAG | 271 | Q12778 | |
| KQGKLRTKVENGEGT | 996 | P55265 | |
| GDTGDKQATQVSIKK | 931 | P51587 | |
| EKTGGKVRQGQSQNK | 636 | O14981 | |
| IKKSQGRKGQEGESC | 131 | Q9UBT3 | |
| KGGNVGKSKRDQIVT | 571 | P61566 | |
| KGGNVGKSKRDQIVT | 571 | P61567 | |
| QIKQGKDGKEGSVGL | 266 | O00311 | |
| TVNAKAAGKGKLDVQ | 896 | P21333 | |
| KIKSGKGKGGTQVDT | 236 | Q9Y2H6 | |
| INKEKPGASQNEGKT | 996 | O75417 | |
| GTLVKSGDGQNVKEK | 2251 | Q8N3K9 | |
| VDGQKFQGAGSNKKV | 561 | Q12906 | |
| GEATNLKKNGDRGEK | 1021 | Q5VZ89 | |
| GSEQKQGEGFKVKTK | 4351 | Q12955 | |
| VQQQKGKTIKLADAG | 226 | Q8NFQ5 | |
| EKQGTIKIQKKGDGD | 476 | Q96PY5 | |
| KGGNVGKSKRDQIVT | 681 | P61565 | |
| CKKGVLNADGTQKGI | 561 | Q6MZM0 | |
| KNLKGVNGGKDFEQD | 856 | Q92538 | |
| KGSGKALAQDVATQK | 116 | Q587J8 | |
| SSGKEQVGIKINGQT | 136 | P20849 | |
| GKNVVTTLLNAGGEK | 596 | Q7Z589 | |
| VTAEDKGTGNKNKIT | 511 | P11021 | |
| SLGSKINVKVGGNSK | 1361 | P0C0L4 | |
| INVKVGGNSKGTLKV | 1366 | P0C0L4 | |
| LQKGLEGKQAGKSRS | 561 | Q5VVW2 | |
| KNDGGKSRKGNIELA | 641 | Q9UPQ0 | |
| ITKGAKVNGRQKNGT | 621 | Q99549 | |
| LSSGVKQKAEGTGKT | 826 | Q13029 | |
| EKKKKTQSSGSGQGS | 1381 | Q9HC10 | |
| KGLEFSEGLAQGKKQ | 121 | Q13253 | |
| GKGGQTIVQLQKETG | 66 | P51513 | |
| KGKNGIGFGKVDITI | 91 | Q8N807 | |
| DKIGKNDAIGKVFVG | 366 | P21579 | |
| AKEGVVGAVEKTKQG | 11 | O76070 | |
| NKKKGEDLVGSLNGG | 561 | Q9P2Y5 | |
| GKQESLQEGKGKKGE | 951 | Q9C093 | |
| DGKKTVKSGEDGIQN | 281 | Q8N3S3 | |
| DQSLQQGEGSKKGKG | 126 | P09132 | |
| TAGKQTGIEVKDFGK | 191 | Q8NF91 | |
| GQTGKVGVNTNLKDL | 296 | A6NFQ2 | |
| TVGQAKSVGKGLQVK | 711 | Q13428 | |
| KTQFGEIGETKKTGN | 651 | Q96NG3 | |
| SKNAGAVIGKGGKNI | 51 | P61978 | |
| GITVTKNDGKKDNNK | 576 | Q92540 | |
| SKQIGGGKAQKVDSD | 2831 | Q9Y520 | |
| VGNGGVLKNKTLGEK | 121 | Q9Y274 | |
| QTNSGNLGKQSEKGK | 111 | Q6ZNX1 | |
| GEKGIQKGVSKGSIS | 361 | Q02383 | |
| GEKDVQKGVSKGSIS | 421 | Q02383 | |
| RQEQAGKNLGTTKKG | 151 | P30520 | |
| TVEILEGKDAGKQGK | 61 | Q96A35 | |
| EGKDAGKQGKVVQVI | 66 | Q96A35 | |
| KGKDIKGVSEIVQNG | 31 | P07148 | |
| GGKGGAKEKISALQS | 306 | P53597 | |
| LKEETFKNDLKGNGG | 396 | Q13023 | |
| ALAGKAKTKGLQSGV | 126 | Q99439 | |
| AKTKGLQSGVDIGVK | 131 | Q99439 | |
| KAAAGQGSVAGKEAK | 131 | Q8N4M7 | |
| LESNGKGAEKNKGLV | 656 | Q70EK8 | |
| GLETVGVKINEKTGK | 451 | Q16881 | |
| LENEGKTENKGKTGD | 41 | Q96EI5 | |
| LKLENQVGGGKNSQK | 476 | Q96HI0 | |
| GAEITGKAIQKGASK | 441 | Q8N0X7 | |
| ENRQKVQKKGKSGEG | 1881 | Q86UP3 | |
| VQKKGKSGEGENTDK | 1886 | Q86UP3 | |
| VIGANKNQEEEKSGK | 456 | Q9Y2W1 | |
| EEALGGLDNSKKQKG | 226 | Q86W11 | |
| KKKGVSGQKDGGQTE | 101 | Q14157 | |
| KAEGTPNQGKKTEGT | 221 | Q9P2E9 | |
| KTEGTPNQGKKAEGT | 231 | Q9P2E9 | |
| KAEGTPNQGKKAEGT | 241 | Q9P2E9 | |
| KAEGAQNQGKKVDTT | 261 | Q9P2E9 | |
| KAEGAQNQAKKVEGA | 291 | Q9P2E9 | |
| KVEGAQNQGKKAEGA | 301 | Q9P2E9 | |
| KAEGAQNQGKKAEGA | 331 | Q9P2E9 | |
| KAEGAQNQGKKAEGA | 341 | Q9P2E9 | |
| KAEGAQNQGKKAEGA | 351 | Q9P2E9 | |
| KAEGAQNQGKKAEGA | 361 | Q9P2E9 | |
| KAEGAQNQGKKAEGA | 371 | Q9P2E9 | |
| KAEGAQNQGKKVEGA | 381 | Q9P2E9 | |
| KVEGAQNQGKKAEGA | 391 | Q9P2E9 | |
| KAEGAQNQGKKAEGA | 401 | Q9P2E9 | |
| KAEGAQNQGKKAEGA | 411 | Q9P2E9 | |
| KAEGAQNQGKKAEGA | 421 | Q9P2E9 | |
| KAEGAQNQGKKAEGA | 431 | Q9P2E9 | |
| KAEGAQNQGKKAEGA | 441 | Q9P2E9 | |
| KAEGAQNQGKKAEGA | 451 | Q9P2E9 | |
| KAEGAQNQGKKVEGA | 461 | Q9P2E9 | |
| KVEGAQNQGKKAEGA | 471 | Q9P2E9 | |
| KAEGAQNQGKKAEGA | 481 | Q9P2E9 | |
| KAEGAQNQGKKAEGA | 491 | Q9P2E9 | |
| KGEGAQNQGKKTEGA | 511 | Q9P2E9 | |
| QGTKVEGITNQGKKA | 556 | Q9P2E9 | |
| KVKVNGKTGNLGNVV | 41 | Q6P5R6 | |
| QAAVKETKGRKIGGN | 566 | Q96T58 | |
| KLAQLKSQGKGAGGE | 446 | P49588 | |
| KTEKVKGRDNGIFGV | 366 | Q9P2N2 | |
| KEKSKKQGEGSSGVS | 226 | O75152 | |
| DKSAKAVEKRGQQGT | 101 | Q96LQ0 | |
| AKGKQATGEEKAATA | 1336 | O95359 | |
| ATIEGQKQGSVKKDQ | 586 | Q2KHR2 | |
| KTVKDYQLVQKGGGQ | 2296 | O43149 | |
| KEIQSKSGDGGSKEK | 851 | Q01118 | |
| KSGDGGSKEKIKQSS | 856 | Q01118 | |
| GSNQLIEAKGKKVRG | 241 | Q15019 | |
| TKGKVGNQVEKSIND | 171 | A6NHJ4 | |
| QGVKKKKSEGSSIGE | 1396 | Q9C0G0 | |
| QGGGKETLKAINTSI | 306 | Q7Z2W7 | |
| SESGVLKGQEAQEKK | 476 | Q5SRN2 | |
| TGVNGRSIKGKTKVE | 71 | Q9NRD5 | |
| KNGGKDCDGLVLQSK | 346 | O95185 | |
| TVKQAKGILGKDVSG | 116 | Q70J99 | |
| INGEDEKGGKNRSKS | 56 | O14544 | |
| TSTEEGKKVLRNGGK | 236 | Q9UBP6 | |
| KNVEAIGLLGGQKSK | 661 | O94782 | |
| QKTGMVGKIEGENSK | 111 | Q5T7N2 |